Irinquiries@prestigebrands.com
Prestige Consumer Healthcare Inc.
660 White Plains Road – Ste 250
Tarrytown, NY 10591
Telephone: 914-524-6819
PRESTIGE
BRANDS HOLDINGS, INC.
|
||||||
(Exact
name of Registrant as specified in its charter)
|
||||||
Delaware
(State
or other jurisdiction of incorporation or organization)
|
20-1297589
(I.R.S.
Employer Identification No.)
|
|||||
90
North Broadway
Irvington,
New York 10533
(Address
of Principal Executive Offices, including zip code)
|
||||||
(914)
524-6810
(Registrant’s
telephone number, including area code)
|
||||||
Securities
registered pursuant to Section 12(b) of the Act:
|
||||||
Title
of each class:
|
Name
on each exchange on which registered:
|
|||||
Common
Stock, par value $.01 per share
|
New
York Stock Exchange
|
|||||
Securities
registered pursuant to Section 12(g) of the Act: None
|
Page
|
||
Part
I
|
||
Item
1.
|
Business
|
1
|
Item
1A.
|
Risk
Factors
|
16
|
Item
1B.
|
Unresolved
Staff Comments
|
25
|
Item
2.
|
Properties
|
25
|
Item
3.
|
Legal
Proceedings
|
26
|
Item
4.
|
Submission
of Matters to a Vote of Security Holders
|
27
|
Part
II
|
||
Item
5.
|
Market
for Registrants’ Common Equity, Related Stockholder
Matters
and Issuer Purchases of Equity Securities
|
28
|
Item
6.
|
Selected
Financial Data
|
30
|
Item
7.
|
Management’s
Discussion and Analysis of Financial Condition
and
Results of Operations
|
33
|
Item
7A.
|
Quantitative
and Qualitative Disclosures About Market Risk
|
51
|
Item
8.
|
Financial
Statements and Supplementary Data
|
51
|
Item
9.
|
Changes
in and Disagreements with Accountants on Accounting
and
Financial Disclosure
|
51
|
Item
9A.
|
Controls
and Procedures
|
51
|
Item
9B.
|
Other
Information
|
52
|
Part
III
|
||
Item
10.
|
Directors,
Executive Officers and Corporate Governance
|
53
|
Item
11.
|
Executive
Compensation
|
53
|
Item
12.
|
Security
Ownership of Certain Beneficial Owners and Management
and
Related Stockholder Matters
|
53
|
Item
13.
|
Certain
Relationships and Related Transactions,
and Director Independence
|
53
|
Item
14.
|
Principal
Accounting Fees and Services
|
53
|
|
||
Part
IV
|
|
|
Item
15.
|
Exhibits
and Financial Statement Schedules
|
54
|
|
||
Trademarks
and Trade Names
|
|
|
Trademarks
and trade names used in this Annual Report on Form 10-K are the property
of Prestige Brands Holdings, Inc. or its subsidiaries, as the case
may be.
We have utilized the ® and TM
symbols the first time each trademark or trade name appears in this
Annual
Report on Form 10-K.
|
|
|
· |
Develop
effective sales, advertising and marketing
programs,
|
· |
Grow
our existing products lines,
|
· |
Acquire
new brands, and
|
· |
Respond
to the technological advances and product introductions of our
competitors.
|
Major Brands
|
Market
Position(1)
|
Market Segment
|
Market
Share
(1)
(%)
|
ACV(1)
(%)
|
||||
Over-the-Counter
Healthcare:
|
||||||||
Chloraseptic®
|
#1
|
Liquid
Sore Throat Relief
|
44.9
|
95
|
||||
Clear
Eyes®
|
#2
|
Redness
Relief
|
16.0
|
87
|
||||
Compound
W®
|
#2
|
Wart
Removal
|
32.1
|
85
|
||||
Wartner®
|
#3
|
Wart
Removal
|
12.1
|
67
|
||||
The
Doctor’s® NightGuard™
|
#1
|
Bruxism
(Teeth Grinding)
|
99.5
|
63
|
||||
The
Doctor’s® Brushpicks™
|
#2
|
Interdental
Picks
|
27.6
|
47
|
||||
Murine®
|
#3
|
Personal
Ear Care
|
13.4
|
65
|
||||
Little
Remedies®(2)
|
N/A
|
Pediatric
Healthcare
|
N/A
|
70
|
||||
New-Skin®
|
#1
|
Liquid
Bandages
|
37.1
|
80
|
||||
Dermoplast®
|
#3
|
Pain
Relief Sprays
|
31.2
|
62
|
||||
|
||||||||
Household
Cleaning:
|
||||||||
Comet®
|
#2
|
Abrasive
Tub and Tile Cleaner
|
30.3
|
99
|
||||
Chore
Boy®
|
#1
|
Soap
Free Metal Scrubbers
|
32.8
|
40
|
||||
Spic
and Span®
|
#6
|
All
Purpose Cleaner
|
3.9
|
58
|
||||
Personal
Care:
|
||||||||
Cutex®
|
#1
|
Nail
Polish Remover
|
27.4
|
93
|
||||
Denorex®
|
#4
|
Medicated
Shampoo
|
5.5
|
48
|
(1) |
The
data included in this Annual Report on Form 10-K regarding the market
share and ranking for our brands, is based on an analysis conducted
by the
Company, based in part on data generated by the independent market
research firm, Information Resources, Inc. (“Information Resources”).
Information Resources reports retail sales data in the food, drug
and mass
merchandise markets. However, Information Resources’ data does not include
Wal-Mart point of sale data, as Wal-Mart ceased providing sales data
to
the industry in 2001. Although Wal-Mart represents a significant
portion
of the mass merchandise market for us, as well as our competitors,
we
believe that Wal-Mart’s exclusion from the Information Resources data
analyzed by the Company above does not significantly change our market
share or ranking relative to our competitors. “Market share” or “market
position” is based on sales dollars
in
the United States, as calculated
|
(2)
|
Market
share information for market segments in which
Little Remedies
products compete is not available from Information
Resources.
|
· |
Investing
in Advertising and
Promotion.
|
· |
Growing
our Categories and Market Share with Innovative New
Products
|
· |
Increasing
Distribution Across Multiple
Channels
|
· |
Growing
Our International
Business
|
· |
Pursuing
Strategic
Acquisitions
|
|
|
Percentage
of
Gross
Sales to
Top
50 Customers (1)
|
||||
Channel of Distribution
|
|
2007
|
2006
|
2005
|
||
Mass
|
|
40.1%
|
|
39.1%
|
|
39.1%
|
Food
|
|
20.4
|
|
22.4
|
|
23.0
|
Drug
|
|
25.8
|
|
23.1
|
|
23.9
|
Dollar
|
|
8.1
|
|
9.6
|
|
9.4
|
Club
|
|
2.6
|
|
3.3
|
|
2.8
|
Other
|
|
2.9
|
|
2.5
|
|
1.8
|
Distribution
Channel
|
|
Customers
|
Distribution
Channel
|
|
Customers
|
|
Mass
|
|
Kmart
|
Drug
|
|
CVS
|
|
|
|
Meijer
|
|
|
Rite
Aid
|
|
|
|
Target
|
|
|
Walgreens
|
|
|
|
Wal-Mart
|
||||
Dollar
|
|
Dollar
General
|
||||
Food
|
|
Ahold
|
|
|
Family
Dollar
|
|
|
|
Kroger
|
|
|
Dollar
Tree
|
|
|
|
Publix
|
||||
|
|
Safeway
|
Club
|
|
Costco
|
|
|
|
Supervalu
|
|
|
Sam’s
Club
|
|
|
|
|
|
BJ’s
Wholesale Club
|
||
· |
Changes
in the legislative or regulatory requirements of the countries or
regions
where we do business,
|
· |
Currency
controls which restrict or prohibit the repatriation of earnings
to the
United States or fluctuations in foreign exchange rates resulting
in
unfavorable increases in the price of our products or cause increases
in
the cost of certain products purchased from our foreign third-party
manufacturers,
|
· |
Regulatory
oversight and its impact on our ability to get products registered
for
sale in certain markets,
|
· |
Potential
trade restrictions and exchange
controls,
|
· |
Inability
to protect our intellectual property rights in these markets,
and
|
· |
Increased
costs of compliance with general business and tax regulations in
these
countries or regions.
|
· |
Difficulties
achieving, or an inability to achieve, our expected
returns,
|
· |
Difficulties
in integrating any acquired companies, personnel and products into
our
existing business,
|
· |
Delays
in realizing the benefits of the acquired company or
products,
|
· |
Higher
costs of integration than we
anticipated,
|
· |
Difficulties
in retaining key employees of the acquired business who are necessary
to
manage the business,
|
· |
Difficulties
in maintaining uniform standards, controls, procedures and policies
throughout our acquired companies,
or
|
· |
Adverse
customer or shareholder reaction to the
acquisition.
|
· |
Suspend
manufacturing operations,
|
· |
Modify
product formulations or processes,
|
· |
Suspend
the sale of products with non-complying
specifications,
|
· |
Initiate
product recalls, or
|
· |
Change
product labeling, packaging or advertising or take other corrective
action.
|
· |
Increase
our vulnerability to general adverse economic and industry
conditions,
|
· |
Require
us to dedicate a substantial portion of our cash flow from operations
to
repay our indebtedness, thereby reducing the availability of our
cash flow
to fund working capital, capital expenditures, acquisitions and
investments and other general corporate
purposes,
|
· |
Limit
our flexibility in planning for, or reacting to, changes in our business
and the markets in which we
operate,
|
· |
Place
us at a competitive disadvantage compared to our competitors that
have
less debt, and
|
· |
Limit,
among other things, our ability to borrow additional funds on favorable
terms or at all.
|
· |
Borrow
money or issue guarantees,
|
· |
Pay
dividends, repurchase stock from or make other restricted payments
to
stockholders,
|
· |
Make
investments,
|
· |
Use
assets as security in other
transactions,
|
· |
Sell
assets or merge with or into other
companies,
|
· |
Enter
into transactions with affiliates,
|
· |
Sell
stock in our subsidiaries, and
|
· |
Direct
our subsidiaries to pay dividends or make other payments to our
company.
|
· |
Increases
and decreases in average quarterly revenues and
profitability,
|
· |
The
rate at which we make acquisitions or develop new products and
successfully market them,
|
· |
Our
inability to increase the sales of our existing products and expand
their
distribution,
|
· |
Changes
in consumer preferences and competitive conditions, including the
effects
of competitors’ operational, promotional or expansion
activities,
|
· |
Seasonality
of our products,
|
· |
Fluctuations
in commodity prices, product costs, utilities and energy costs, prevailing
wage rates, insurance costs and other
costs,
|
· |
Our
ability to recruit, train and retain qualified employees, and the
costs
associated with those activities,
|
· |
Changes
in advertising and promotional activities and expansion to new
markets,
|
· |
Negative
publicity relating to us and the products we
sell,
|
· |
Unanticipated
increases in infrastructure costs,
|
· |
Impairment
of goodwill or long-lived assets,
|
· |
Changes
in interest rates, and
|
· |
Changes
in accounting, tax, regulatory or other rules applicable to our
business.
|
ITEM 5.
|
MARKET
FOR REGISTRANT’S COMMON EQUITY, RELATED STOCKHOLDER MATTERS AND ISSUER
PURCHASES OF EQUITY
SECURITIES
|
Year
Ended March 31, 2007
|
High
|
Low
|
|||||
Quarter
Ended:
|
|||||||
June
30, 2006
|
$
|
12.90
|
$
|
8.25
|
|||
September
30, 2006
|
11.55
|
8.50
|
|||||
December
31, 2006
|
13.87
|
10.77
|
|||||
March
31, 2007
|
13.53
|
10.80
|
|||||
Year
Ended March 31, 2006
|
|||||||
Quarter
Ended:
|
|||||||
June
30, 2005
|
$
|
19.67
|
$
|
15.80
|
|||
September
30, 2005
|
21.15
|
10.50
|
|||||
December
31, 2005
|
12.50
|
9.39
|
|||||
March
31, 2006
|
13.13
|
10.22
|
February
9,
|
March
31
|
||||||||||||
2005
(1)
|
2005
|
2006
|
2007
|
||||||||||
Prestige
Brands Holdings
|
$
|
100.00
|
$
|
110.31
|
$
|
76.06
|
$
|
74.06
|
|||||
The
Peer Group Index (2)
|
100.00
|
97.33
|
117.96
|
131.29
|
|||||||||
The
Russell 2000 Index
|
100.00
|
98.57
|
122.61
|
127.78
|
|||||||||
The
S&P Supercomposite Index
|
100.00
|
101.32
|
106.25
|
122.91
|
(In
Thousands, except per share data)
|
Year
Ended March 31
|
|||||||||
2007
|
2006
|
2005
|
||||||||
Income
Statement Data
|
||||||||||
Total
revenues
|
$
|
318,634
|
$
|
296,668
|
$
|
289,069
|
||||
Cost
of sales (1)
|
153,147
|
139,430
|
139,009
|
|||||||
Gross
profit
|
165,487
|
157,238
|
150,060
|
|||||||
Advertising
and promotion expenses
|
32,005
|
32,082
|
29,697
|
|||||||
Depreciation
and amortization
|
10,384
|
10,777
|
9,800
|
|||||||
General
and administrative
|
28,416
|
21,158
|
20,198
|
|||||||
Impairment
of intangible assets and
goodwill
|
--
|
9,317
|
--
|
|||||||
Interest
expense, net
|
39,506
|
36,346
|
44,726
|
|||||||
Other
expense (2)
|
--
|
--
|
26,863
|
|||||||
Income
before income taxes
|
55,176
|
47,558
|
18,776
|
|||||||
Provision
for income taxes
|
19,098
|
21,281
|
8,556
|
|||||||
Net
income
|
36,078
|
26,277
|
10,220
|
|||||||
Cumulative
preferred dividends on
Senior
Preferred
and Class B Preferred
units
|
--
|
--
|
(25,395
|
)
|
||||||
Net
income (loss) available to common stockholders
|
$
|
36,078
|
$
|
26,277
|
$
|
(15,175
|
)
|
|||
Net
income (loss) per common share:
|
||||||||||
Basic
|
$
|
0.73
|
$
|
0.54
|
$
|
(0.55
|
)
|
|||
Diluted
|
$
|
0.72
|
$
|
0.53
|
$
|
(0.55
|
)
|
|||
Weighted
average shares outstanding:
|
||||||||||
Basic
|
49,460
|
48,908
|
27,546
|
|||||||
Diluted
|
50,020
|
50,008
|
27,546
|
|||||||
|
Year
Ended March 31
|
|||||||||
Other
Financial Data
|
2007
|
|
|
2006
|
|
|
2005
|
|
||
Capital
expenditures
|
$
|
540
|
$
|
519
|
$
|
365
|
||||
Cash
provided by (used in):
|
||||||||||
Operating
activities
|
71,899
|
53,861
|
51,042
|
|||||||
Investing
activities
|
(31,051
|
)
|
(54,163
|
)
|
(425,844
|
)
|
||||
Financing
activities
|
(35,290
|
)
|
3,168
|
376,743
|
||||||
March
31
|
||||||||||
Balance
Sheet Data
|
2007
|
|
|
2006
|
|
|
2005
|
|||
Cash
and cash equivalents
|
$
|
13,758
|
$
|
8,200
|
$
|
5,334
|
||||
Total
assets
|
1,063,416
|
1,038,645
|
996,600
|
|||||||
Total
long-term debt, including current
maturities
|
463,350
|
498,630
|
495,360
|
|||||||
Stockholders’
equity
|
445,334
|
409,407
|
382,047
|
(In
Thousands, except per share data)
|
February
6, 2004 to March 31,
|
April
1, 2003 to February 5,
|
Year
Ended
March
31
|
|||||||
2004
|
2004
|
2003
|
||||||||
Income
Statement Data
|
(Successor)
|
(Predecessor)
|
||||||||
Total
revenues
|
$
|
16,876
|
$
|
68,402
|
$
|
71,734
|
||||
Cost
of sales (1)
|
9,351
|
26,855
|
27,017
|
|||||||
Gross
profit
|
7,525
|
41,547
|
44,717
|
|||||||
Advertising
and promotion expenses
|
1,267
|
10,061
|
11,116
|
|||||||
Depreciation
and amortization
|
931
|
4,498
|
5,274
|
|||||||
General
and administrative
|
1,649
|
12,068
|
12,075
|
|||||||
Interest
expense, net
|
1,725
|
8,157
|
9,747
|
|||||||
Other
expense
|
--
|
1,404
|
685
|
|||||||
Income
before income taxes
|
1,953
|
5,359
|
5,820
|
|||||||
Provision
for income taxes
|
724
|
2,214
|
3,287
|
|||||||
Income
from continuing operations
|
1,229
|
3,145
|
2,533
|
|||||||
Loss
from discontinued operations
|
--
|
--
|
(5,644
|
)
|
||||||
Cumulative
effect of change in
accounting
principle
|
--
|
--
|
(11,785
|
)
|
||||||
Net
income (loss)
|
1,229
|
$
|
3,145
|
$
|
(14,896
|
)
|
||||
Cumulative
preferred dividends on
Senior
Preferred
and Class B
Preferred
units
|
(1,390
|
)
|
||||||||
Net
loss available to members and
common
stockholders
|
$
|
(161
|
)
|
|||||||
Basic
and diluted net loss
per
share
|
$
|
(0.01
|
)
|
|||||||
Basic
and diluted weighted average
shares
outstanding
|
24,472
|
|||||||||
February
6, 2004 to
March
31,
|
|
|
April
1, 2003 to February 5,
|
|
|
Year
Ended March 31
|
|
|||
Other
Financial Data:
|
|
|
2004
|
|
|
2004
|
|
|
2003
|
|
Capital
expenditures
|
$
|
42
|
$
|
66
|
$
|
421
|
||||
Cash
provided by (used in):
|
||||||||||
Operating
activities
|
(1,706
|
)
|
7,843
|
12,519
|
||||||
Investing
activities
|
(166,874
|
)
|
(576
|
)
|
(2,165
|
)
|
||||
Financing
activities
|
171,973
|
(8,629
|
)
|
(14,708
|
)
|
|||||
Balance
Sheet Data:
|
March
31, 2004
|
|
|
February
5, 2004
|
|
|
March
31, 2003
|
|||
Cash
and cash equivalents
|
$
|
3,393
|
$
|
2,868
|
$
|
3,530
|
||||
Total
assets
|
325,358
|
145,130
|
142,056
|
|||||||
Total
long-term debt, including
current
maturities
|
148,694
|
71,469
|
81,866
|
|||||||
Members’/Stockholders’
equity
|
125,948
|
50,122
|
43,858
|
(1)
|
For
the period from February 6, 2004 to March 31, 2004 and for 2005,
2006 and
2007, cost of sales includes $1.8 million, $5.3 million, $248,000
and
$276,000, respectively, of charges related to the step-up of
inventory.
|
(2) |
For
2005, other expense includes a loss on debt extinguishment of $26.9
million.
|
ITEM 7.
|
MANAGEMENT’S
DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF
OPERATION
|
Over-the-
Counter
Healthcare
|
Household
Cleaning
|
Personal
Care
|
Consolidated
|
||||||||||
Goodwill
|
$
|
235,647
|
$
|
72,549
|
$
|
2,751
|
$
|
310,947
|
|||||
Intangible
assets
|
|||||||||||||
Indefinite
lived
|
374,070
|
170,893
|
--
|
544,963
|
|||||||||
Finite
lived
|
94,776
|
21
|
17,397
|
112,194
|
|||||||||
468,846
|
170,914
|
17,397
|
657,157
|
||||||||||
$
|
704,493
|
$
|
243,463
|
$
|
20,148
|
$
|
968,104
|
· |
Brand
History
|
· |
Market
Position
|
· |
Recent
and Projected Sales Growth
|
· |
History
of and Potential for Product
Extensions
|
· |
Reviews
period-to-period sales and profitability by
brand,
|
· |
Analyzes
industry trends and projects brand growth
rates,
|
· |
Prepares
annual sales forecasts,
|
· |
Evaluates
advertising effectiveness,
|
· |
Analyzes
gross margins,
|
· |
Reviews
contractual benefits or
limitations,
|
· |
Monitors
competitors’ advertising spend and product
innovation,
|
· |
Prepares
projections to measure brand viability over the estimated useful
life of
the intangible asset, and
|
· |
Considers
the regulatory environment, as well as industry
litigation.
|
· |
Type
of instrument (i.e.: restricted shares vs. an option, warrant or
performance shares),
|
· |
Strike
price of the instrument,
|
· |
Market
price of the Company’s common stock on the date of
grant,
|
· |
Discount
rates,
|
· |
Duration
of the instrument, and
|
· |
Volatility
of the Company’s common stock in the public
market.
|
· |
Rules
and regulations promulgated by regulatory
agencies,
|
· |
Sufficiency
of the evidence in support of our
position,
|
· |
Anticipated
costs to support our position, and
|
· |
Likelihood
of a positive outcome.
|
2007
Revenues
|
%
|
2006
Revenues
|
%
|
Increase
(Decrease)
|
%
|
||||||||||||||
OTC
Healthcare
|
$
|
174,704
|
54.8
|
$
|
160,942
|
54.3
|
$
|
13,762
|
8.6
|
||||||||||
Household
Cleaning
|
119,036
|
37.4
|
107,801
|
36.3
|
11,235
|
10.4
|
|||||||||||||
Personal
Care
|
24,894
|
7.8
|
27,925
|
9.4
|
(3,031
|
)
|
(10.9)
|
|
|||||||||||
|
|||||||||||||||||||
$
|
318,634
|
100.0
|
$
|
296,668
|
100.0
|
$
|
21,966
|
7.4
|
2007
Gross
Profit
|
%
|
2006
Gross
Profit
|
%
|
Increase
(Decrease)
|
%
|
||||||||||||||
OTC
Healthcare
|
109,103
|
62.5
|
$
|
102,451
|
63.7
|
$
|
6,652
|
6.5
|
|||||||||||
Household
Cleaning
|
46,034
|
38.7
|
42,713
|
39.6
|
3,321
|
7.8
|
|||||||||||||
Personal
Care
|
10,350
|
41.6
|
12,074
|
43.2
|
(1,724
|
)
|
(14.3)
|
|
|||||||||||
$
|
165,487
|
51.9
|
$
|
157,238
|
53.0
|
$
|
8,249
|
5.2
|
2007
Contribution
Margin
|
%
|
2006
Contribution
Margin
|
%
|
Increase
(Decrease)
|
%
|
||||||||||||||
OTC
Healthcare
|
$
|
84,902
|
48.6
|
$
|
80,027
|
49.7
|
$
|
4,875
|
6.1
|
||||||||||
Household
Cleaning
|
39,355
|
33.1
|
36,218
|
33.6
|
3,137
|
8.7
|
|||||||||||||
Personal
Care
|
9,225
|
37.1
|
8,911
|
31.9
|
314
|
3.5
|
|||||||||||||
|
|
|
|||||||||||||||||
$
|
133,482
|
41.9
|
$
|
125,156
|
42.2
|
$
|
8,326
|
6.7
|
2006
Revenues
|
%
|
2005
Revenues
|
%
|
Increase
(Decrease)
|
%
|
||||||||||||||
|
|||||||||||||||||||
OTC
Healthcare
|
$
|
160,942
|
54.3
|
$
|
159,010
|
55.0
|
$
|
1,932
|
1.2
|
||||||||||
Household
Cleaning
|
107,801
|
36.3
|
97,897
|
33.9
|
9,904
|
10.1
|
|||||||||||||
Personal
Care
|
27,925
|
9.4
|
32,162
|
11.1
|
(4,237
|
)
|
(13.2)
|
|
|||||||||||
|
|
|
|||||||||||||||||
$
|
296,668
|
100.0
|
$
|
289,069
|
100.0
|
$
|
7,599
|
2.6
|
2006
Gross
Profit
|
%
|
2005
Gross
Profit
|
%
|
Increase
(Decrease)
|
%
|
||||||||||||||
OTC
Healthcare
|
$
|
102,451
|
63.7
|
$
|
98,440
|
61.9
|
$
|
4,011
|
4.1
|
||||||||||
Household
Cleaning
|
42,713
|
39.6
|
35,858
|
36.6
|
6,855
|
19.1
|
|||||||||||||
Personal
Care
|
12,074
|
43.2
|
15,762
|
49.0
|
(3,688
|
)
|
(23.4)
|
|
|||||||||||
|
|||||||||||||||||||
$
|
157,238
|
53.0
|
$
|
150,060
|
51.9
|
$
|
7,178
|
4.8
|
2006
Contribution
Margin
|
%
|
2005
Contribution
Margin
|
%
|
Increase
(Decrease)
|
%
|
||||||||||||||
OTC
Healthcare
|
$
|
80,027
|
|
49.7
|
$
|
79,897
|
50.2
|
$
|
130
|
0.2
|
|||||||||
Household
Cleaning
|
36,218
|
|
33.6
|
30,202
|
30.9
|
6,016
|
19.9
|
||||||||||||
Personal
Care
|
8,911
|
31.9
|
10,264
|
31.9
|
(1,353
|
)
|
(13.2)
|
|
|||||||||||
$
|
125,156
|
42.2
|
$
|
120,363
|
41.6
|
$
|
4,793
|
4.0
|
Year
Ended March 31
|
||||||||||
(In
thousands)
|
2007
|
2006
|
2005
|
|||||||
Net
cash provided by (used in):
|
|
|
|
|||||||
Operating
activities
|
$
|
71,899
|
$
|
53,861
|
$
|
51,042
|
||||
Investing
activities
|
(31,051
|
)
|
(54,163
|
)
|
(425,844
|
)
|
||||
Financing
activities
|
(35,290
|
)
|
3,168
|
376,743
|
· |
An
increase of net income of $9.8 million from $26.3 million for 2006
to
$36.1 million for 2007,
|
· |
An
improvement of $22.3 million in the components of operating assets
and
liabilities as a result of net operating assets and liabilities decreasing
by $11.8 million in 2007 compared to an increase of $10.5 million
in
2006, offset by
|
|
· | A decrease in non-cash expenses of $14.1 million from $38.1 million for 2006 to $24.0 million for 2007. |
· |
An
increase in net income of $16.1 million from $10.2 million for 2005
to
$26.3 million for 2006,
|
· |
A
deterioration of $3.4 million in the components of operating assets
and
liabilities as a result of net operating assets and liabilities increasing
by $10.5 million in 2006 compared to an increase of $7.1 million
in 2005,
and
|
· |
A
decrease in non-cash expenses of $9.8 million from $47.9 million
for 2005
to $38.1 million for 2006.
|
· |
$337.4
million of borrowings under the Tranche B Term Loan Facility,
and
|
· |
$126.0
million of 9.25% Senior Subordinated Notes due
2012.
|
· |
Have
a leverage ratio of less than 5.0 to 1.0 for the quarter ended March
31,
2007, decreasing over time to 3.75 to 1.0 for the quarter ending
September
30, 2010, and remaining level
thereafter,
|
· |
Have
an interest coverage ratio of greater than 2.75 to 1.0 for the quarter
ended March 31, 2007, increasing over time to 3.25 to 1.0 for the
quarter
ending March 31, 2010, and
|
· |
Have
a fixed charge coverage ratio of greater than 1.5 to 1.0 for the
quarter
ended March 31, 2007, and for each quarter thereafter until the quarter
ending March 31, 2011.
|
Payments
Due by Period
|
||||||||||||||||
(In
Millions)
|
Less than
|
1 to 3
|
4 to 5
|
After 5
|
||||||||||||
Contractual
Obligations
|
Total
|
1 Year
|
Years
|
Years
|
Years
|
|||||||||||
Long-term
debt
|
$
|
463.4
|
$
|
3.6
|
$
|
7.1
|
$
|
326.7
|
$
|
126.0
|
||||||
Interest
on long-term debt (1)
|
160.0
|
37.5
|
74.0
|
48.5
|
--
|
|||||||||||
Operating
leases
|
1.5
|
0.7
|
0.8
|
--
|
--
|
|||||||||||
Total
contractual cash
obligations
|
$
|
624.9
|
$
|
41.8
|
$
|
81.9
|
$
|
375.2
|
$
|
126.0
|
(1) |
Represents
the estimated interest obligations on the outstanding balances of
the
Revolving Credit Facility, Tranche B Term Loan Facility and Senior
Subordinated Notes, together, assuming scheduled principal payments
(based
on the terms of the loan agreements) were made and assuming a weighted
average interest rate of 8.07%. Estimated interest obligations would
be
different under different assumptions regarding interest rates or
timing
of principal payments. If interest rates on borrowings with variable
rates
increased by 1%, interest expense would increase approximately $3.4
million, in the first year. However, given the protection afforded
by the
interest rate cap agreements, the impact of a one percentage point
increase would be limited to $2.7
million.
|
· |
General
economic conditions affecting our products and their respective
markets,
|
· |
The
high level of competition in our industry and
markets,
|
· |
Our
dependence on a limited number of customers for a large portion of
our
sales,
|
· |
Disruptions
in our distribution center,
|
· |
Acquisitions
or other strategic transactions diverting managerial resources, or
incurrence of additional liabilities or integration problems associated
with such transactions,
|
· |
Changing
consumer trends or pricing pressures which may cause us to lower
our
prices,
|
· |
Increases
in supplier prices,
|
· |
Increases
in transportation and fuel charges,
|
· |
Changes
in our senior management team,
|
· |
Our
ability to protect our intellectual property
rights,
|
· |
Our
dependency on the reputation of our brand
names,
|
· |
Shortages
of supply of sourced goods or interruptions in the manufacturing
of our
products,
|
· |
Our
level of debt, and ability to service our
debt,
|
· |
Any
adverse judgments rendered in any pending litigation or
arbitration,
|
· |
Our
ability to obtain additional financing,
and
|
· |
The
restrictions imposed by our senior credit facility and the indenture
on
our operations.
|
ITEM 7A.
|
QUANTITATIVE
AND QUALITATIVE DISCLOSURES ABOUT MARKET
RISK
|
ITEM
9.
|
CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS ON ACCOUNTING AND FINANCIAL
DISCLOSURE
|
SECURITY
OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT AND RELATED
STOCKHOLDER MATTERS
|
CERTAIN
RELATIONSHIPS AND RELATED TRANSACTIONS, DIRECTOR
INDEPENDENCE
|
Prestige
Brands Holdings, Inc.
|
Report
of Independent Registered Public Accounting Firm,
PricewaterhouseCoopers
LLP
|
Consolidated
Statements of Operations for each of the three years in
the
period ended
March 31, 2007
|
Consolidated
Balance Sheets at March 31, 2007 and 2006
|
Consolidated
Statements of Members’ and Stockholders’ Equity and
Comprehensive
Income for each of the three years in the period ended March 31,
2007
|
Consolidated
Statements of Cash Flows for each of the three years
in
the period ended
March 31, 2007
|
Notes
to Consolidated Financial Statements
|
Schedule
II—Valuation and Qualifying Accounts
|
|
Signature
|
|
Title
|
Date
|
|
/s/
MARK
PETTIE
|
|
Chairman
of the Board
and
Chief Executive Officer
|
June
14, 2007
|
|
Mark
Pettie
|
|
(Principal
Executive Officer)
|
||
/s/
PETER
J. ANDERSON
|
|
Chief
Financial Officer
|
June
14, 2007
|
|
Peter
J. Anderson
|
|
(Principal
Financial Officer and
|
||
Principal
Accounting Officer)
|
||||
/s/
L. DICK BUELL
|
|
Director
|
June
14, 2007
|
|
L.
Dick Buell
|
|
|
||
/s/
JOHN E. BYOM
|
Director
|
June
14, 2007
|
||
John
E. Byom
|
||||
/s/
GARY E. COSTLEY
|
|
Director
|
June
14, 2007
|
|
Gary
E. Costley
|
|
|
||
/s/
DAVID A. DONNINI
|
|
Director
|
June
14, 2007
|
|
David
A. Donnini
|
|
|
||
/s/
RONALD B. GORDON
|
|
Director
|
June
14, 2007
|
|
Ronald
B. Gordon
|
|
|
||
/s/
VINCENT J. HEMMER
|
|
Director
|
June
14, 2007
|
|
Vincent
J. Hemmer
|
|
|
||
/s/
PATRICK M. LONERGAN
|
|
Director
|
June
14, 2007
|
|
Patrick
M. Lonergan
|
|
|
||
/s/
PETER C. MANN
|
Director
|
June
14, 2007
|
||
Peter
C. Mann
|
||||
/s/
RAYMOND P. SILCOCK
|
Director
|
June
14, 2007
|
||
Raymond
P. Silcock
|
Report
of Independent Registered Public Accounting Firm, PricewaterhouseCoopers
LLP
|
F-1
|
|
Consolidated
Statements of Operations for each of the three years in
the
period ended March 31, 2007
|
F-3
|
|
Consolidated
Balance Sheets at March 31, 2007 and 2006
|
F-4
|
|
Consolidated
Statements of Members’ and Stockholders’ Equity and Comprehensive
Income
for each of the
three years in the period ended March 31, 2007
|
F-5
|
|
Consolidated
Statements of Cash Flows for each of the three year
in
the period
ended March 31, 2007
|
F-9
|
|
Notes
to Consolidated Financial Statements
|
F-11
|
|
Schedule
II—Valuation and Qualifying Accounts
|
F-37
|
|
Year
Ended March 31
|
||||||||||
(In
thousands, except per share data)
|
2007
|
2006
|
2005
|
|||||||
Revenues
|
||||||||||
Net
sales
|
$
|
316,847
|
$
|
296,239
|
$
|
288,918
|
||||
Other
revenues
|
1,787
|
429
|
151
|
|||||||
Total
revenues
|
318,634
|
296,668
|
289,069
|
|||||||
Cost
of Sales
|
||||||||||
Cost
of sales
|
153,147
|
139,430
|
139,009
|
|||||||
Gross
profit
|
165,487
|
157,238
|
150,060
|
|||||||
Operating
Expenses
|
||||||||||
Advertising
and promotion
|
32,005
|
32,082
|
29,697
|
|||||||
General
and administrative
|
28,416
|
21,158
|
20,198
|
|||||||
Depreciation
|
744
|
1,736
|
1,899
|
|||||||
Amortization
of intangible assets
|
9,640
|
9,041
|
7,901
|
|||||||
Impairment
of goodwill
|
--
|
1,892
|
--
|
|||||||
Impairment
of intangible asset
|
--
|
7,425
|
--
|
|||||||
Total
operating expenses
|
70,805
|
73,334
|
59,695
|
|||||||
Operating
income
|
94,682
|
83,904
|
90,365
|
|||||||
Other
income (expense)
|
||||||||||
Interest
income
|
972
|
568
|
371
|
|||||||
Interest
expense
|
(40,478
|
)
|
(36,914
|
)
|
(45,097
|
)
|
||||
Loss
on disposal of equipment
|
--
|
--
|
(9
|
)
|
||||||
Loss
on extinguishment of debt
|
--
|
--
|
(26,854
|
)
|
||||||
Total
other income (expense)
|
(39,506
|
)
|
(36,346
|
)
|
(71,589
|
)
|
||||
Income
before income taxes
|
55,176
|
47,558
|
18,776
|
|||||||
Provision
for income taxes
|
(19,098
|
)
|
(21,281
|
)
|
(8,556
|
)
|
||||
Net
income
|
36,078
|
26,277
|
10,220
|
|||||||
Cumulative
preferred dividends on Senior
Preferred
and Class
B Preferred Units
|
--
|
--
|
(25,395
|
)
|
||||||
Net
income (loss) available to members and
common
stockholders
|
$
|
36,078
|
$
|
26,277
|
$
|
(15,175
|
)
|
|||
Basic
earnings (loss) per share
|
$
|
0.73
|
$
|
0.54
|
$
|
(0.55
|
)
|
|||
Diluted
earnings (loss) per share
|
$
|
0.72
|
$
|
0.53
|
$
|
(0.55
|
)
|
|||
Weighted
average shares outstanding:
Basic
|
49,460
|
48,908
|
27,546
|
|||||||
Diluted
|
50,020
|
50,008
|
27,546
|
Assets
|
March
31, 2007
|
March
31, 2006
|
|||||
Current
assets
|
|||||||
Cash
and cash equivalents
|
$
|
13,758
|
$
|
8,200
|
|||
Accounts
receivable
|
35,167
|
40,042
|
|||||
Inventories
|
30,173
|
33,841
|
|||||
Deferred
income tax assets
|
2,735
|
3,227
|
|||||
Prepaid
expenses and other current assets
|
1,935
|
701
|
|||||
Total
current assets
|
83,768
|
86,011
|
|||||
Property
and equipment
|
1,449
|
1,653
|
|||||
Goodwill
|
310,947
|
297,935
|
|||||
Intangible
assets
|
657,157
|
637,197
|
|||||
Other
long-term assets
|
10,095
|
15,849
|
|||||
Total
Assets
|
$
|
1,063,416
|
$
|
1,038,645
|
|||
Liabilities
and Stockholders’ Equity
|
|||||||
Current
liabilities
|
|||||||
Accounts
payable
|
$
|
19,303
|
$
|
18,065
|
|||
Accrued
interest payable
|
7,552
|
7,563
|
|||||
Income
taxes payable
|
--
|
1,795
|
|||||
Other
accrued liabilities
|
10,505
|
4,582
|
|||||
Current
portion of long-term debt
|
3,550
|
3,730
|
|||||
Total
current liabilities
|
40,910
|
35,735
|
|||||
Long-term
debt
|
459,800
|
494,900
|
|||||
Other
long-term liabilities
|
2,801
|
--
|
|||||
Deferred
income tax liabilities
|
114,571
|
98,603
|
|||||
Total
Liabilities
|
618,082
|
629,238
|
|||||
Commitments
and Contingencies - Note 15
|
|||||||
Stockholders’
Equity
|
|||||||
Preferred
stock - $0.01 par value
|
|||||||
Authorized
- 5,000 shares
|
|||||||
Issued
and outstanding - None
|
--
|
--
|
|||||
Common
stock - $0.01 par value
|
|||||||
Authorized
- 250,000 shares
|
|||||||
Issued
- 50,060 shares and 50,056 shares at March 31,
2007
and 2006,
respectively
|
501
|
501
|
|||||
Additional
paid-in capital
|
379,225
|
378,570
|
|||||
Treasury
stock, at cost - 55 shares and 18 shares at
March 31,
2007 and 2006, respectively
|
(40
|
)
|
(30
|
)
|
|||
Accumulated
other comprehensive income
|
313
|
1,109
|
|||||
Retained
earnings
|
65,335
|
29,257
|
|||||
Total
stockholders’ equity
|
445,334
|
409,407
|
|||||
Total
Liabilities and Stockholders’ Equity
|
$
|
1,063,416
|
$
|
1,038,645
|
Senior
Preferred
Units
|
Class
B
Preferred
Units
|
Common
Units
|
Common
Stock
|
||||||||||||||||||||||
(In
thousands)
|
Units
|
Amount
|
Units
|
Amount
|
Units
|
Amount
|
Shares
|
Amount
|
|||||||||||||||||
Balances
at March 31, 2004
|
23
|
$
|
17,768
|
107
|
$
|
96,807
|
57,902
|
$
|
5,273
|
--
|
$
|
--
|
|||||||||||||
Issuance
of Preferred and Common
Units
for
cash
|
--
|
--
|
58
|
58,385
|
1,839
|
148
|
--
|
--
|
|||||||||||||||||
Issuance
of Preferred and Common
Units
in
conjunction with the Bonita
Bay
Acquisition
|
--
|
--
|
--
|
91
|
19
|
1
|
--
|
--
|
|||||||||||||||||
Repurchase/cancellation
of Preferred and
Common
Units in
conjunction with the
Bonita
Bay
Acquisition
|
--
|
--
|
(2
|
)
|
--
|
(1,987
|
)
|
(46
|
)
|
--
|
--
|
||||||||||||||
Issuance
of restricted Common Units to
management
for
cash
|
--
|
--
|
--
|
--
|
337
|
235
|
--
|
--
|
|||||||||||||||||
Exchange
of Common Units for
Common
Stock
|
--
|
--
|
--
|
--
|
(58,110
|
)
|
(5,611
|
)
|
26,666
|
267
|
|||||||||||||||
Issuance
of Common Stock in Initial
Public
Offering,
net
|
--
|
--
|
--
|
--
|
--
|
--
|
28,000
|
280
|
|||||||||||||||||
Redemption
of Preferred Units
|
(23
|
)
|
(17,768
|
)
|
(163
|
)
|
(155,283
|
)
|
--
|
--
|
--
|
--
|
|||||||||||||
Retirement
of Common Stock
|
--
|
--
|
--
|
--
|
--
|
--
|
(4,666
|
)
|
(47
|
)
|
|||||||||||||||
Purchase
of Treasury Stock
|
--
|
--
|
--
|
--
|
--
|
--
|
--
|
--
|
|||||||||||||||||
Components
of comprehensive income
|
|||||||||||||||||||||||||
Net
income
|
--
|
--
|
--
|
--
|
--
|
--
|
--
|
--
|
|||||||||||||||||
Unrealized
gain on interest rate caps,
net
of income tax
expense of $200
|
--
|
--
|
--
|
--
|
--
|
--
|
--
|
--
|
|||||||||||||||||
Total
comprehensive income
|
--
|
--
|
--
|
--
|
--
|
--
|
--
|
--
|
|||||||||||||||||
Balances
at March 31, 2005
|
--
|
$
|
-
|
--
|
$
|
--
|
--
|
$
|
--
|
50,000
|
$
|
500
|
Prestige
Brands Holdings, Inc.
Consolidated
Statement of Changes in Members’
and
Stockholders’ Equity and Comprehensive Income
(Continued)
|
|||||||||||||||||||
Additional
Paid-in
|
Treasury
Stock
|
Accumulated
Other
Comprehensive
Income
|
Retained
Earnings
(Accumulated
|
||||||||||||||||
Capital
|
Shares |
Amount
|
(Loss)
|
Deficit)
|
Total
|
||||||||||||||
(In
thousands)
|
|||||||||||||||||||
Balances
at March 31, 2004
|
$
|
4,871
|
--
|
$
|
--
|
$
|
--
|
$
|
1,229
|
$
|
125,948
|
||||||||
Issuance
of Preferred and Common
Units
for
cash
|
--
|
--
|
--
|
--
|
--
|
58,533
|
|||||||||||||
Issuance
of Preferred and Common Units
in
conjunction with
the Bonita
Bay
Acquisition
|
--
|
--
|
--
|
--
|
--
|
92
|
|||||||||||||
Repurchase/cancellation
of Preferred and
Common
Units in
conjunction with the
Bonita
Bay
Acquisition
|
--
|
--
|
--
|
--
|
--
|
(46
|
)
|
||||||||||||
Issuance
of restricted Common Units to
management
for
cash
|
--
|
--
|
--
|
--
|
--
|
235
|
|||||||||||||
Exchange
of Common Units for
Common
Stock
|
5,344
|
--
|
--
|
--
|
--
|
--
|
|||||||||||||
Issuance
of Common Stock in Initial
Public
Offering,
net
|
416,552
|
--
|
--
|
--
|
--
|
416,832
|
|||||||||||||
Redemption
of Preferred Units
|
(18,315
|
)
|
--
|
--
|
--
|
(8,469
|
)
|
(199,835
|
)
|
||||||||||
Retirement
of Common Stock
|
(30,201
|
)
|
--
|
--
|
--
|
--
|
(30,248
|
)
|
|||||||||||
Purchase
of Treasury Stock
|
--
|
2
|
(4
|
)
|
--
|
--
|
(4
|
)
|
|||||||||||
Components
of comprehensive income
|
|||||||||||||||||||
Net
income
|
--
|
--
|
--
|
--
|
10,220
|
10,220
|
|||||||||||||
Unrealized
gain on interest rate caps,
net
of income tax expense of $200
|
--
|
--
|
--
|
320
|
--
|
320
|
|||||||||||||
Total
comprehensive income
|
--
|
--
|
--
|
--
|
--
|
10,540
|
|||||||||||||
Balances
at March 31, 2005
|
$
|
378,251
|
2
|
$
|
(4
|
)
|
$
|
320
|
$
|
2,980
|
$
|
382,047
|
Common
Stock
Par
Shares Value
|
Additional
Paid-in
Capital
|
Treasury
Stock
Shares Amount
|
Accumulated
Other
Comprehensive
Income
|
Retained
Earnings
|
Totals
|
||||||||||||||||||||
(In
thousands)
|
|||||||||||||||||||||||||
Balances
at March 31, 2005
|
50,000
|
$
|
500
|
$
|
378,251
|
2
|
$
|
(4
|
)
|
$
|
320
|
$
|
2,980
|
$
|
382,047
|
||||||||||
Additional
costs associated with initial public offering
|
--
|
--
|
(63
|
)
|
--
|
--
|
--
|
--
|
(63
|
)
|
|||||||||||||||
Stock-based
compensation
|
56
|
1
|
382
|
--
|
--
|
--
|
--
|
383
|
|||||||||||||||||
Purchase
of common stock for treasury
|
--
|
--
|
--
|
16
|
(26
|
)
|
--
|
--
|
(26
|
)
|
|||||||||||||||
Components
of comprehensive income
|
|||||||||||||||||||||||||
Net
income
|
--
|
--
|
--
|
--
|
--
|
--
|
26,277
|
26,277
|
|||||||||||||||||
Amortization
of interest rate caps reclassified into earnings, net of income tax
expense of $192
|
--
|
--
|
--
|
--
|
--
|
298
|
--
|
298
|
|||||||||||||||||
Unrealized
gain on interest rate caps, net of income tax expense of
$208
|
--
|
--
|
--
|
--
|
--
|
491
|
--
|
491
|
|||||||||||||||||
Total
comprehensive income
|
--
|
--
|
--
|
--
|
--
|
--
|
--
|
27,066
|
|||||||||||||||||
Balances
at March 31, 2006
|
50,056
|
$
|
501
|
$
|
378,570
|
18
|
$
|
(30
|
)
|
$
|
1,109
|
$
|
29,257
|
$
|
409,407
|
Common
Stock
Par
Shares
Value
|
Additional
Paid-in
Capital
|
Treasury
Stock
Shares
Amount
|
Accumulated
Other
Comprehensive
Income
|
Retained
Earnings
|
Totals
|
||||||||||||||||||||
(In
thousands)
|
|||||||||||||||||||||||||
Balances
at March 31, 2006
|
50,056
|
$
|
501
|
$
|
378,570
|
18
|
$
|
(30
|
)
|
$
|
1,109
|
$
|
29,257
|
$
|
409,407
|
||||||||||
Stock-based
compensation
|
4
|
655
|
655
|
||||||||||||||||||||||
Purchase
of common stock for treasury
|
37
|
(10
|
)
|
(10
|
)
|
||||||||||||||||||||
Components
of comprehensive income
|
|||||||||||||||||||||||||
Net
income
|
36,078
|
36,078
|
|||||||||||||||||||||||
Amortization of interest rate caps
reclassified into earnings, net of
income tax expense of $429
|
678
|
678
|
|||||||||||||||||||||||
Unrealized loss on interest rate caps, net
of income tax benefit of $931
|
(1,474
|
)
|
(1,474
|
)
|
|||||||||||||||||||||
Total
comprehensive income
|
35,282
|
||||||||||||||||||||||||
Balances
at March 31, 2007
|
50,060
|
$
|
501
|
$
|
379,225
|
55
|
$
|
(40
|
)
|
$
|
313
|
$
|
65,335
|
$
|
445,334
|
Year
Ended March 31
|
||||||||||
(In
thousands)
|
2007
|
2006
|
2005
|
|||||||
Operating
Activities
|
||||||||||
Net
income
|
$
|
36,078
|
$
|
26,277
|
$
|
10,220
|
||||
Adjustments
to reconcile net income to net cash provided
by operating activities:
|
||||||||||
Depreciation
and amortization
|
10,384
|
10,777
|
9,800
|
|||||||
Amortization
of financing costs
|
3,257
|
2,649
|
2,943
|
|||||||
Impairment
of goodwill and intangible assets
|
--
|
9,317
|
--
|
|||||||
Deferred
income taxes
|
9,662
|
14,976
|
8,344
|
|||||||
Stock-based
compensation
|
655
|
383
|
--
|
|||||||
Loss
on extinguishment of debt
|
--
|
--
|
26,854
|
|||||||
Other
|
--
|
--
|
9
|
|||||||
Changes
in operating assets and liabilities, net of effects
of purchases of businesses
|
||||||||||
Accounts
receivable
|
4,875
|
(1,350
|
)
|
(7,227
|
)
|
|||||
Inventories
|
4,292
|
(7,156
|
)
|
2,922
|
||||||
Prepaid
expenses and other assets
|
(1,235
|
)
|
2,623
|
(1,490
|
)
|
|||||
Accounts
payable
|
(186
|
)
|
(6,037
|
)
|
5,059
|
|||||
Income
taxes payable
|
(1,795
|
)
|
1,795
|
--
|
||||||
Other
accrued liabilities
|
5,912
|
(393
|
)
|
(6,392
|
)
|
|||||
Net
cash provided by operating activities
|
71,899
|
53,861
|
51,042
|
|||||||
Investing
Activities
|
||||||||||
Purchases
of equipment
|
(540
|
)
|
(519
|
)
|
(365
|
)
|
||||
Purchases
of intangible assets
|
--
|
(22,655
|
)
|
--
|
||||||
Change
in other assets due to purchase price adjustments
|
750
|
--
|
--
|
|||||||
Purchases
of businesses, net
|
(31,261
|
)
|
(30,989
|
)
|
(425,479
|
)
|
||||
Net
cash used for investing activities
|
(31,051
|
)
|
(54,163
|
)
|
(425,844
|
)
|
||||
Financing
Activities
|
||||||||||
Proceeds
from the issuance of notes
|
--
|
30,000
|
698,512
|
|||||||
Payment
of deferred financing costs
|
--
|
(13
|
)
|
(24,539
|
)
|
|||||
Repayment
of notes
|
(35,280
|
)
|
(26,730
|
)
|
(529,538
|
)
|
||||
Prepayment
penalty
|
--
|
--
|
(10,875
|
)
|
||||||
Payments
on interest rate caps
|
--
|
--
|
(2,283
|
)
|
||||||
Proceeds
from the issuance of equity, net
|
--
|
(63
|
)
|
475,554
|
||||||
Redemption
of equity interests
|
(10
|
)
|
(26
|
)
|
(230,088
|
)
|
||||
Net
cash provided by (used for) financing activities
|
(35,290
|
)
|
3,168
|
376,743
|
||||||
Increase
in cash
|
5,558
|
2,866
|
1,941
|
|||||||
Cash
- beginning of period
|
8,200
|
5,334
|
3,393
|
|||||||
Cash
- end of period
|
$
|
13,758
|
$
|
8,200
|
$
|
5,334
|
Year
Ended March 31
|
||||||||||
2007
|
2006
|
2005
|
||||||||
Supplemental
Cash Flow Information
|
||||||||||
Purchases
of Businesses
|
||||||||||
Fair
value of assets acquired, net of cash acquired
|
$
|
42,115
|
$
|
34,706
|
$
|
655,542
|
||||
Fair
value of liabilities assumed
|
(10,854
|
)
|
(3,717
|
)
|
(229,971
|
)
|
||||
Purchase
price funded with non-cash contributions
|
--
|
--
|
(92
|
)
|
||||||
Cash
paid to purchase businesses
|
$
|
31,261
|
$
|
30,989
|
$
|
425,479
|
||||
Interest
paid
|
$
|
37,234
|
$
|
33,760
|
$
|
42,155
|
||||
Income
taxes paid
|
$
|
11,751
|
$
|
2,852
|
$
|
2,689
|
1.
|
Business
and Basis
of Presentation
|
Years
|
|
Machinery
|
5
|
Computer
equipment
|
3
|
Furniture
and fixtures
|
7
|
Leasehold
improvements
|
5
|
2.
|
Acquisition
of
Businesses
|
(In
thousands)
Revolving
Credit Facility
|
$
|
3,512
|
||
Tranche
B Term Loan Facility
|
355,000
|
|||
Tranche
C Term Loan Facility
|
100,000
|
|||
9.25%
Senior Subordinated Notes
|
210,000
|
|||
Issuance
of Preferred and Common units
|
58,579
|
|||
Total
sources of funds
|
$
|
727,091
|
(In
thousands)
Cash
|
$
|
4,304
|
||
Accounts
receivable
|
13,186
|
|||
Inventories
|
16,185
|
|||
Prepaid
expenses and other current assets
|
1,391
|
|||
Property
and equipment
|
2,982
|
|||
Goodwill
|
217,234
|
|||
Intangible
assets
|
352,460
|
|||
Accounts
payable and accrued liabilities
|
(21,189
|
)
|
||
Long-term
debt
|
(172,898
|
)
|
||
Deferred
income taxes
|
(34,429
|
)
|
||
$
|
379,226
|
(In
thousands)
Accounts
receivable
|
$
|
2,136
|
||
Inventories
|
910
|
|||
Prepaid
expenses and other current assets
|
37
|
|||
Property
and equipment
|
5
|
|||
Goodwill
|
21,858
|
|||
Intangible
assets
|
27,158
|
|||
Accounts
payable and accrued liabilities
|
(1,455
|
)
|
||
$
|
50,649
|
(In
thousands)
|
||||
Accounts
receivable
|
$
|
2,774
|
||
Inventories
|
1,707
|
|||
Prepaid
expenses and other current assets
|
172
|
|||
Property
and equipment
|
546
|
|||
Goodwill
|
6,362
|
|||
Intangible
assets
|
22,395
|
|||
Accounts
payable and accrued liabilities
|
(3,717
|
)
|
||
$
|
30,239
|
(In
thousands)
|
||||
Inventory
|
$
|
769
|
||
Intangible
assets
|
29,600
|
|||
Goodwill
|
11,746
|
|||
Accrued
liabilities
|
(3,854
|
)
|
||
Deferred
tax liabilities
|
(7,000
|
)
|
||
$
|
31,261
|
Year
Ended March 31
|
||||||||||
(In
thousands, except per share data)
|
2007
|
2006
|
2005
|
|||||||
(Unaudited
Pro forma)
|
||||||||||
Revenues
|
$
|
326,103
|
$
|
315,276
|
$
|
308,062
|
||||
Income
before provision for income taxes
|
$
|
55,340
|
$
|
47,368
|
$
|
20,730
|
||||
Net
income
|
$
|
36,178
|
$
|
26,161
|
$
|
11,418
|
||||
Cumulative
preferred dividends on Senior
Preferred
and Class
B Preferred Units
|
--
|
--
|
(25,395
|
)
|
||||||
Net
income (loss) available to members and
common
stockholders
|
$
|
36,178
|
$
|
26,161
|
$
|
(13,977
|
)
|
|||
Basic
earnings per share
|
$
|
0.73
|
$
|
0.53
|
$
|
(0.51
|
)
|
|||
Diluted
earnings per share
|
$
|
0.72
|
$
|
0.52
|
$
|
(0.51
|
)
|
|||
Weighted
average shares outstanding:
Basic
|
49,460
|
48,908
|
27,546
|
|||||||
Diluted
|
50,020
|
50,008
|
27,546
|
Accounts
Receivable
|
March
31
|
|||||||
2007
|
2006
|
||||||
Accounts
receivable
|
$
|
35,274
|
$
|
40,140
|
|||
Other
receivables
|
1,681
|
1,870
|
|||||
36,955
|
42,010
|
||||||
Less
allowances for discounts, returns and
uncollectible
accounts
|
(1,788
|
)
|
(1,968
|
)
|
|||
$
|
35,167
|
$
|
40,042
|
Inventories
|
March
31
|
|||||||
2007
|
2006
|
||||||
Packaging
and raw materials
|
$
|
2,842
|
$
|
3,278
|
|||
Finished
goods
|
27,331
|
30,563
|
|||||
$
|
30,173
|
$
|
33,841
|
March
31
|
|||||||
2007
|
2006
|
||||||
Machinery
|
$
|
1,480
|
$
|
3,722
|
|||
Computer
equipment
|
566
|
987
|
|||||
Furniture
and fixtures
|
247
|
303
|
|||||
Leasehold
improvements
|
372
|
340
|
|||||
2,665
|
5,352
|
||||||
Accumulated
depreciation
|
(1,216
|
)
|
(3,699
|
)
|
|||
$
|
1,449
|
$
|
1,653
|
Over-the-Counter
|
Household
|
Personal
|
|||||||||||
Healthcare
|
Cleaning
|
Care
|
Consolidated
|
||||||||||
Balance
- March 31, 2005
|
$
|
217,539
|
72,549
|
$
|
4,643
|
$
|
294,731
|
||||||
Additions
|
5,096
|
--
|
--
|
5,096
|
|||||||||
Impairments
|
--
|
--
|
(1,892
|
)
|
(1,892
|
)
|
|||||||
Balance
- March 31, 2006
|
222,635
|
72,549
|
2,751
|
297,935
|
|||||||||
Additions
|
13,012
|
--
|
--
|
13,012
|
|||||||||
Balance
- March 31, 2007
|
$
|
235,647
|
$
|
72,549
|
$
|
2,751
|
$
|
310,947
|
Year
Ended March 31, 2007
|
|||||||||||||
Indefinite
Lived
|
Finite
Lived
|
Non
Compete
|
|||||||||||
Trademarks
|
Trademarks
|
Agreement
|
Totals
|
||||||||||
Carrying
Amounts
|
|||||||||||||
Balance
- March 31, 2006
|
$
|
544,963
|
$
|
109,870
|
$
|
196
|
$
|
655,029
|
|||||
Additions
|
--
|
29,600
|
--
|
29,600
|
|||||||||
Balance
- March 31, 2007
|
$
|
544,963
|
$
|
139,470
|
$
|
196
|
$
|
684,629
|
|||||
Accumulated
Amortization
|
|||||||||||||
Balance
- March 31, 2006
|
$
|
--
|
$
|
17,779
|
$
|
53
|
$
|
17,832
|
|||||
Additions
|
--
|
9,596
|
44
|
9,640
|
|||||||||
Balance
- March 31, 2007
|
$
|
--
|
$
|
27,375
|
$
|
97
|
$
|
27,472
|
Year
Ended March 31, 2006
|
|||||||||||||
Indefinite
Lived
|
Finite
Lived
|
Non
Compete
|
|||||||||||
Trademarks
|
Trademarks
|
Agreement
|
Totals
|
||||||||||
Carrying
Amounts
|
|||||||||||||
Balance
- March 31, 2005
|
$
|
522,346
|
$
|
94,900
|
$
|
158
|
$
|
617,404
|
|||||
Additions
|
22,617
|
22,395
|
38
|
45,050
|
|||||||||
Impairments
|
--
|
(7,425
|
)
|
--
|
(7,425
|
)
|
|||||||
Balance
- March 31, 2006
|
$
|
544,963
|
$
|
109,870
|
$
|
196
|
$
|
655,029
|
|||||
Accumulated
Amortization
|
|||||||||||||
Balance
- March 31, 2005
|
$
|
--
|
$
|
8,775
|
$
|
16
|
$
|
8,791
|
|||||
Additions
|
--
|
9,004
|
37
|
9,041
|
|||||||||
Balance
- March 31, 2006
|
$
|
--
|
$
|
17,779
|
$
|
53
|
$
|
17,832
|
Year
Ending March 31
|
||||
2008
|
$
|
10,507
|
||
2009
|
10,502
|
|||
2010
|
9,086
|
|||
2011
|
9,071
|
|||
2012
|
9,071
|
|||
Thereafter
|
63,957
|
|||
$
|
112,194
|
|
March
31
|
|
||||||||
|
2007
|
2006
|
||||||||
|
||||||||||
Accrued
marketing costs
|
$
|
5,687
|
$
|
2,513
|
||||||
Accrued
payroll
|
3,721
|
813
|
||||||||
Accrued
commissions
|
335
|
248
|
||||||||
Other
|
762
|
1,008
|
||||||||
|
$
|
10,505
|
$
|
4,582
|
March
31
|
|||||||
2007
|
2006
|
||||||
Senior
revolving credit facility (“Revolving Credit Facility”), which expires on
April 6, 2009 and is available for maximum borrowings of up to $60.0
million. The Revolving Credit Facility bears interest at the Company’s
option at either the prime rate plus a variable margin or LIBOR plus
a
variable margin. The variable margins range from 0.75% to 2.50% and
at
March 31, 2007, the interest rate on the Revolving Credit Facility
was
9.5% per annum. The Company is also required to pay a variable commitment
fee on the unused portion of the Revolving Credit Facility. At March
31,
2007, the commitment fee was 0.50% of the unused line. The Revolving
Credit Facility is collateralized by substantially all of the Company’s
assets.
|
$
|
--
|
$
|
7,000
|
|||
Senior
secured term loan facility (“Tranche B Term Loan Facility”) that bears
interest at the Company’s option at either the prime rate plus a margin of
1.25% or LIBOR plus a margin of 2.25%. At March
31, 2007,
the applicable interest rate on the Tranche B Term Loan Facility
was
7.63%. Principal payments of $887,500 plus accrued interest are payable
quarterly. In February 2005, the Tranche B Term Loan Facility was
amended
to increase the additional amount available thereunder by $50.0 million
to
$200.0 million, all of which is available at March
31, 2007.
Current amounts outstanding under the Tranche B Term Loan Facility
mature
on April 6, 2011, while amounts borrowed pursuant to the amendment
will
mature on October 6, 2011. The Tranche B Term Loan Facility is
collateralized by substantially all of the Company’s
assets.
|
337,350
|
365,630
|
|||||
Senior
Subordinated Notes that bear interest at 9.25% which is payable on
April
15th
and October 15th
of
each year. The Senior Subordinated Notes mature on April 15, 2012;
however, the Company may redeem some or all of the Senior Subordinated
Notes on or prior to April 15, 2008 at a redemption price equal to
100%,
plus a make-whole premium, and after April 15, 2008 at redemption
prices
set forth in the indenture governing the Senior Subordinated Notes.
The
Senior Subordinated Notes are unconditionally guaranteed by Prestige
Brands Holdings, Inc., and its domestic wholly-owned subsidiaries
other
than Prestige Brands, Inc., the issuer. Each of these guarantees
is joint
and several. There are no significant restrictions on the ability
of any
of the guarantors to obtain funds from their subsidiaries.
|
126,000
|
126,000
|
|||||
463,350
|
498,630
|
||||||
Current
portion of long-term debt
|
(3,550
|
)
|
(3,730
|
)
|
|||
$
|
459,800
|
$
|
494,900
|
Year
Ending March 31
|
||||
2008
|
$
|
3,550
|
||
2009
|
3,550
|
|||
2010
|
3,550
|
|||
2011
|
3,550
|
|||
2012
|
323,150
|
|||
Thereafter
|
126,000
|
|||
$
|
463,350
|
Year
Ended March 31
|
||||||||||
2007
|
2006
|
2005
|
||||||||
Numerator
|
||||||||||
Net
income
|
$
|
36,078
|
$
|
26,277
|
$
|
10,220
|
||||
Cumulative
preferred dividends on Senior
Preferred
and Class
B Preferred Units
|
--
|
--
|
(25,395
|
)
|
||||||
Net
income (loss) available to members
and
common
stockholders
|
$
|
36,078
|
$
|
26,277
|
$
|
(15,175
|
)
|
|||
Denominator
|
||||||||||
Denominator
for basic earnings per share
|
49,460
|
48,908
|
27,546
|
|||||||
Dilutive
effect of unvested restricted
common
stock and
stock appreciation
rights
issued to
employees and directors
|
560
|
1,100
|
--
|
|||||||
Denominator
for diluted earnings per share
|
50,020
|
50,008
|
27,546
|
|||||||
Earnings
per Common Share:
|
||||||||||
Basic
|
$
|
0.73
|
$
|
0.54
|
$
|
(0.55
|
)
|
|||
Diluted
|
$
|
0.72
|
$
|
0.53
|
$
|
(0.55
|
)
|
13.
|
Share-Based
Compensation
|
Nonvested
Shares
|
Shares
(000)
|
Weighted-
Average
Grant-Date
Fair
Value
|
|||||
Granted
|
211.6
|
$
|
12.29
|
||||
Vested
|
(7.1)
|
|
11.25
|
||||
Forfeited
|
(6.5)
|
|
12.32
|
||||
Nonvested
at March 31, 2006
|
198.0
|
12.32
|
|||||
|
|||||||
Granted
|
156.5
|
9.83
|
|||||
Vested
|
(13.1)
|
|
10.67
|
||||
Forfeited
|
(47.0)
|
|
12.47
|
||||
Nonvested
at March 31, 2007
|
294.4
|
$
|
11.05
|
Year
Ended March 31
|
|||||||
2007
|
2006
|
||||||
Expected
volatility
|
--
|
31.0%
|
|
||||
Expected
dividends
|
--
|
--
|
|||||
Expected
term in years
|
--
|
6.0
|
|||||
Risk-free
rate
|
--
|
4.2%
|
|
Options
|
Shares
(000)
|
Weighted-
Average
Exercise
Price
|
Weighted-
Average
Remaining
Contractual
Term
|
Aggregate
Intrinsic
Value
(000)
|
|||||||||
Granted
|
61.8
|
$
|
12.95
|
5.0
|
$
|
--
|
|||||||
Exercised
|
--
|
--
|
--
|
--
|
|||||||||
Forfeited
or expired
|
--
|
--
|
--
|
--
|
|||||||||
Outstanding
at March 31, 2006
|
61.8
|
12.95
|
4.3
|
--
|
|||||||||
|
|
||||||||||||
Granted
|
--
|
--
|
--
|
--
|
|||||||||
Exercised
|
--
|
--
|
--
|
--
|
|||||||||
Forfeited
or expired
|
(61.8)
|
|
12.95
|
4.3
|
--
|
||||||||
Outstanding
at March 31, 2007
|
--
|
$
|
--
|
--
|
$
|
--
|
|||||||
|
|
||||||||||||
Exercisable
at March 31, 2007
|
--
|
$
|
--
|
--
|
$
|
--
|
Year
Ended
March
31, 2007
|
||
Expected
volatility
|
50.0%
|
|
Expected
dividends
|
--
|
|
Expected
term in years
|
2.75
|
|
Risk-free
rate
|
5.0%
|
SARS
|
Shares
(000)
|
Grant
Date
Stock
Price
|
Weighted-
Average
Remaining
Contractual
Term
|
Aggregate
Intrinsic
Value
(000)
|
|||||||||
Granted
|
16.1
|
$
|
9.97
|
2.0
|
$
|
--
|
|||||||
Forfeited
or expired
|
--
|
--
|
-- |
--
|
|||||||||
Outstanding
at March 31, 2007
|
16.1
|
$
|
9.97
|
2.0
|
$
|
30,300
|
|||||||
Exercisable
at March 31, 2007
|
--
|
$
|
--
|
--
|
$
|
--
|
Year
Ended March 31
|
||||||||||
2007
|
2006
|
2005
|
||||||||
Current
|
||||||||||
Federal
|
$
|
7,547
|
$
|
5,043
|
$
|
(544
|
)
|
|||
State
|
1,739
|
1,056
|
654
|
|||||||
Foreign
|
150
|
206
|
102
|
|||||||
Deferred
|
||||||||||
Federal
|
10,391
|
10,621
|
7,495
|
|||||||
State
|
(729
|
)
|
4,355
|
849
|
||||||
$
|
19,098
|
$
|
21,281
|
$
|
8,556
|
March
31
|
|||||||
2007
|
2006
|
||||||
Deferred
Tax Assets
|
|||||||
Allowance
for doubtful accounts and sales returns
|
$
|
982
|
$
|
1,975
|
|||
Inventory
capitalization
|
420
|
524
|
|||||
Inventory
reserves
|
731
|
420
|
|||||
Net
operating loss carryforwards
|
1,052
|
2,402
|
|||||
Property
and equipment
|
95
|
325
|
|||||
State
income taxes
|
4,545
|
5,319
|
|||||
Accrued
liabilities
|
286
|
233
|
|||||
Other
|
347
|
168
|
|||||
Deferred
Tax Liabilities
|
|||||||
Intangible
assets
|
(120,096
|
)
|
(106,342
|
)
|
|||
Interest
rate caps
|
(198
|
)
|
(400
|
)
|
|||
$
|
(111,836
|
)
|
$
|
(95,376
|
)
|
Year
Ended March 31
|
|||||||||||||||||||
2007
|
2006
|
2005
|
|||||||||||||||||
%
|
%
|
%
|
|||||||||||||||||
Income
tax provision at
statutory
rate
|
$
|
19,312
|
35.0
|
$
|
16,645
|
35.0
|
$
|
6,384
|
34.0
|
||||||||||
Foreign
tax provision
|
(69
|
)
|
(0.1
|
)
|
59
|
0.1
|
102
|
0.5
|
|||||||||||
State
income taxes, net of
federal
income tax
benefit
|
2,029
|
3.7
|
2,096
|
4.4
|
901
|
4.8
|
|||||||||||||
Increase
in net deferred tax
liability
resulting
from an
increase
in federal
tax rate
to
35%
|
--
|
--
|
--
|
--
|
1,147
|
6.2
|
|||||||||||||
Increase
(decrease) in net
deferred
tax
liability
resulting
from an
increase
(decrease)
in the
effective
state
tax
rate
|
(2,200
|
)
|
(4.0
|
)
|
2,019
|
4.2
|
--
|
--
|
|||||||||||
Goodwill
|
--
|
--
|
461
|
1.0
|
--
|
--
|
|||||||||||||
Other
|
26
|
0.0
|
1
|
0.0
|
22
|
0.1
|
|||||||||||||
Provision
for income taxes
|
$
|
19,098
|
34.6
|
$
|
21,281
|
44.7
|
$
|
8,556
|
45.6
|
Facilities
|
Equipment
|
Total
|
||||||||
Year
Ending March 31,
|
||||||||||
2008
|
$
|
612
|
$
|
120
|
$
|
732
|
||||
2009
|
501
|
113
|
614
|
|||||||
2010
|
75
|
85
|
160
|
|||||||
2011
|
--
|
25
|
25
|
|||||||
$
|
1,188
|
$
|
343
|
$
|
1,531
|
Year
Ended March 31, 2007
|
|||||||||||||
Over-the-Counter
|
Household
|
Personal
|
|||||||||||
Healthcare
|
Cleaning
|
Care
|
Consolidated
|
||||||||||
Net
sales
|
$
|
174,704
|
$
|
117,249
|
$
|
24,894
|
$
|
316,847
|
|||||
Other
revenues
|
--
|
1,787
|
--
|
1,787
|
|||||||||
Total
revenues
|
174,704
|
119,036
|
24,894
|
318,634
|
|||||||||
Cost
of sales
|
65,601
|
73,002
|
14,544
|
153,147
|
|||||||||
Gross
profit
|
109,103
|
46,034
|
10,350
|
165,487
|
|||||||||
Advertising
and promotion
|
24,201
|
6,679
|
1,125
|
32,005
|
|||||||||
Contribution
margin
|
$
|
84,902
|
$
|
39,355
|
$
|
9,225
|
133,482
|
||||||
Other
operating expenses
|
38,800
|
||||||||||||
Operating
income
|
94,682
|
||||||||||||
Other
(income) expense
|
39,506
|
||||||||||||
Provision
for income taxes
|
19,098
|
||||||||||||
Net
income
|
$
|
36,078
|
Year
Ended March 31, 2006
|
|||||||||||||
Over-the-Counter
|
Household
|
Personal
|
|||||||||||
Healthcare
|
Cleaning
|
Care
|
Consolidated
|
||||||||||
Net
sales
|
$
|
160,942
|
$
|
107,372
|
$
|
27,925
|
$
|
296,239
|
|||||
Other
revenues
|
--
|
429
|
--
|
429
|
|||||||||
Total
revenues
|
160,942
|
107,801
|
27,925
|
296,668
|
|||||||||
Cost
of sales
|
58,491
|
65,088
|
15,851
|
139,430
|
|||||||||
Gross
profit
|
102,451
|
42,713
|
12,074
|
157,238
|
|||||||||
Advertising
and promotion
|
22,424
|
6,495
|
3,163
|
32,082
|
|||||||||
Contribution
margin
|
$
|
80,027
|
$
|
36,218
|
$
|
8,911
|
125,156
|
||||||
Other
operating expenses
|
41,252
|
||||||||||||
Operating
income
|
83,904
|
||||||||||||
Other
(income) expense
|
36,346
|
||||||||||||
Provision
for income taxes
|
21,281
|
||||||||||||
Net
income
|
$
|
26,277
|
Year
Ended March 31, 2005
|
|||||||||||||
Over-the-Counter
|
Household
|
Personal
|
|||||||||||
Healthcare
|
Cleaning
|
Care
|
Consolidated
|
||||||||||
Net
sales
|
$
|
159,010
|
$
|
97,746
|
$
|
32,162
|
$
|
288,918
|
|||||
Other
revenues
|
--
|
151
|
--
|
151
|
|||||||||
Total
revenues
|
159,010
|
97,897
|
32,162
|
289,069
|
|||||||||
Cost
of sales
|
60,570
|
62,039
|
16,400
|
139,009
|
|||||||||
Gross
profit
|
98,440
|
35,858
|
15,762
|
150,060
|
|||||||||
Advertising
and promotion
|
18,543
|
5,656
|
5,498
|
29,697
|
|||||||||
Contribution
margin
|
$
|
79,897
|
$
|
30,202
|
$
|
10,264
|
120,363
|
||||||
Other
operating expenses
|
29,998
|
||||||||||||
Operating
income
|
90,365
|
||||||||||||
Other
(income) expense
|
71,589
|
||||||||||||
Provision
for income taxes
|
8,556
|
||||||||||||
Net
income
|
$
|
10,220
|
Over-the-Counter
|
Household
|
Personal
|
|||||||||||
Healthcare
|
Cleaning
|
Care
|
Consolidated
|
||||||||||
Goodwill
|
$
|
235,647
|
$
|
72,549
|
$
|
2,751
|
$
|
310,947
|
|||||
Intangible
assets
|
|||||||||||||
Indefinite
lived
|
374,070
|
170,893
|
--
|
544,963
|
|||||||||
Finite
lived
|
94,776
|
21
|
17,397
|
112,194
|
|||||||||
468,846
|
170,914
|
17,397
|
657,157
|
||||||||||
$
|
704,493
|
$
|
243,463
|
$
|
20,148
|
$
|
968,104
|
Quarterly
Period Ended
|
|||||||||||||
(In
thousands, except for
per
share data)
|
June
30,
2006
|
September
30,
2006
|
December
31,
2006
|
March
31,
2007
|
|||||||||
Total
revenues
|
$
|
75,923
|
$
|
84,551
|
$
|
80,124
|
$
|
78,036
|
|||||
Cost
of sales
|
36,325
|
41,259
|
36,766
|
38,797
|
|||||||||
Gross
profit
|
39,598
|
43,292
|
43,358
|
39,239
|
|||||||||
Operating
expenses
|
|||||||||||||
Advertising
and promotion
|
7,402
|
9,455
|
8,952
|
6,196
|
|||||||||
Depreciation
and amortization
|
2,413
|
2,412
|
2,804
|
2,755
|
|||||||||
General
and administrative
|
6,434
|
7,259
|
7,068
|
7,655
|
|||||||||
16,249
|
19,126
|
18,824
|
16,606
|
||||||||||
Operating
income
|
23,349
|
24,166
|
24,534
|
22,633
|
|||||||||
Net
interest expense
|
(9,792
|
)
|
(9,743
|
)
|
(10,156
|
)
|
(9,815
|
)
|
|||||
Income
before income taxes
|
13,557
|
14,423
|
14,378
|
12,818
|
|||||||||
Provision
for income taxes
|
(5,301
|
)
|
(5,639
|
)
|
(3,735
|
)
|
(4,423
|
)
|
|||||
Net
income
|
$
|
8,256
|
$
|
8,784
|
$
|
10,643
|
$
|
8,395
|
|||||
Net
income per share:
|
|||||||||||||
Basic
|
$
|
0.17
|
$
|
0.18
|
$
|
0.21
|
$
|
0.17
|
|||||
Diluted
|
$
|
0.17
|
$
|
0.18
|
$
|
0.21
|
$
|
0.17
|
|||||
Weighted
average shares outstanding:
|
|||||||||||||
Basic
|
49,372
|
49,451
|
49,535
|
49,607
|
|||||||||
Diluted
|
50,005
|
49,994
|
50,024
|
50,027
|
Quarterly
Period Ended
|
|||||||||||||
(In
thousands, except for
per
share data)
|
June
30,
2005
|
September
30,
2005
|
December
31,
2005
|
March
31,
2006
|
|||||||||
Total
revenues
|
$
|
63,453
|
$
|
73,345
|
$
|
79,856
|
$
|
80,014
|
|||||
Cost
of sales
|
28,949
|
35,549
|
38,726
|
36,206
|
|||||||||
Gross
profit
|
34,504
|
37,796
|
41,130
|
43,808
|
|||||||||
Operating
expenses
|
|||||||||||||
Advertising
and promotion
|
8,705
|
10,217
|
7,385
|
5,775
|
|||||||||
Depreciation
and amortization
|
2,631
|
2,635
|
2,834
|
2,694
|
|||||||||
General
and administrative
|
4,911
|
4,117
|
6,159
|
5,954
|
|||||||||
Other
expenses (1)
|
--
|
--
|
--
|
9,317
|
|||||||||
16,247
|
16,969
|
16,378
|
23,740
|
||||||||||
Operating
income
|
18,257
|
20,827
|
24,752
|
20,068
|
|||||||||
Net
interest expense
|
(8,510
|
)
|
(8,671
|
)
|
(9,526
|
)
|
(9,639
|
)
|
|||||
Income
before income taxes
|
9,747
|
12,156
|
15,226
|
10,429
|
|||||||||
Provision
for income taxes
|
(3,818
|
)
|
(4,782
|
)
|
(5,881
|
)
|
(6,800
|
)
|
|||||
Net
income
|
$
|
5,929
|
$
|
7,374
|
$
|
9,345
|
$
|
3,629
|
|||||
Net
income per share:
|
|||||||||||||
Basic
|
$
|
0.12
|
$
|
0.15
|
$
|
0.19
|
$
|
0.07
|
|||||
Diluted
|
$
|
0.12
|
$
|
0.15
|
$
|
0.19
|
$
|
0.07
|
|||||
Weighted
average shares outstanding:
|
|||||||||||||
Basic
|
48,722
|
48,791
|
48,929
|
49,077
|
|||||||||
Diluted
|
49,998
|
49,949
|
50,010
|
50,008
|
(1)
|
Consists
of a $7.4 million charge for the impairment of intangible assets
and a
$1.9 million charge for the impairment of
goodwill.
|
(In
Thousands)
|
Balance
at
Beginning
of
Year
|
Amounts
Charged
to
Expense
|
Deductions
|
Other
|
Balance
at
End
of
Year
|
||||||||||||||
Year
Ended March 31, 2007
|
|||||||||||||||||||
Reserves
for sales
returns
and
allowance
|
$
|
1,868
|
$
|
12,611
|
$
|
(12,726
|
)
|
$
|
--
|
$
|
1,753
|
||||||||
Reserves
for trade
promotions
|
1,671
|
2,974
|
(2,484
|
)
|
--
|
2,161
|
|||||||||||||
Reserves
for consumer
coupon
redemptions
|
283
|
2,674
|
(2,556
|
)
|
--
|
401
|
|||||||||||||
Allowance
for doubtful
accounts
|
100
|
100
|
(165
|
)
|
--
|
35
|
|||||||||||||
Allowance
for
inventory
obsolescence
|
1,019
|
3,096
|
(2,397
|
)
|
136
|
(1
|
)
|
1,854
|
|||||||||||
Year
Ended March 31, 2006
|
|||||||||||||||||||
Reserves
for sales
returns
and
allowance
|
$
|
1,652
|
$
|
13,040
|
$
|
(13,056
|
)
|
$
|
232
|
(2
|
)
|
$
|
1,868
|
||||||
Reserves
for trade
promotions
|
1,493
|
2,522
|
(2,481
|
)
|
137
|
(2
|
)
|
1,671
|
|||||||||||
Reserves
for consumer
coupon
redemptions
|
290
|
2,680
|
(2,687
|
)
|
--
|
283
|
|||||||||||||
Allowance
for doubtful
accounts
|
250
|
1
|
(92
|
)
|
(59
|
)
|
(2
|
)
|
100
|
||||||||||
Allowance
for inventory
obsolescence
|
1,450
|
76
|
(526
|
)
|
19
|
(2
|
)
|
1,019
|
|||||||||||
Pecos
returns reserve
|
242
|
--
|
(242
|
)
|
--
|
--
|
|||||||||||||
Year
Ended March 31, 2005
|
|||||||||||||||||||
Reserves
for sales
returns
and
allowance
|
$
|
687
|
$
|
10,245
|
$
|
(9,280
|
)
|
$
|
--
|
$
|
1,652
|
||||||||
Reserves
for trade
promotions
|
1,163
|
10,120
|
(11,660
|
)
|
1,870
|
(3
|
)
|
1,493
|
|||||||||||
Reserves
for consumer
coupon
redemptions
|
266
|
2,265
|
(2,891
|
)
|
650
|
(3
|
)
|
290
|
|||||||||||
Allowance
for doubtful
accounts
|
60
|
32
|
(33
|
)
|
191
|
(3
|
)
|
250
|
|||||||||||
Allowance
for inventory
obsolescence
|
124
|
769
|
(266
|
)
|
823
|
(3
|
)
|
1,450
|
|||||||||||
Pecos
returns reserve
|
1,186
|
--
|
(944
|
)
|
--
|
242
|
|||||||||||||
2.1
|
Asset
Sale and Purchase Agreement, dated July 22, 2005, by and among
Reckitt Benckiser Inc., Reckitt Benckiser (Canada) Inc., Prestige
Brands
Holdings, Inc. and The Spic and Span Company (filed as Exhibit 2.1 to
Prestige Brands Holdings, Inc.’s Form 8-K filed on July 28,
2005).+
|
|
2.2
|
Unit
Purchase Agreement, dated as of November 9, 2005, by and between
Prestige
Brands Holdings, Inc., and each of Dental Concepts LLC, Richard
Gaccione,
Combined Consultants DBPT Gordon Wade, Douglas A.P. Hamilton, Islandia
L.P., George O’Neill, Abby O’Neill, Michael Porter, Marc Cole and Michael
Lesser (filed as Exhibit 10.1 to Prestige Brands Holdings, Inc.’s Form
10-Q filed on February 14, 2006).+
|
|
2.3
|
Stock
Sale and Purchase Agreement, dated as of September 21, 2006, by
Lil’ Drug
Store Products, Inc., Wartner USA B.V., Lil’ Drug Store Products, Inc.’s
shareholders set forth on the signature thereto, and Medtech Products
Inc.
(filed as Exhibit 2.1 to Prestige Brands Holdings, Inc.’s Form 10-Q filed
on November 9, 2006).+
|
|
3.1
|
|
Amended
and Restated Certificate of Incorporation of Prestige Brands
Holdings, Inc. (filed
as Exhibit 3.1 to Prestige Brands Holdings, Inc.’s Form S-1/A filed on
February 8, 2005).+
|
3.2
|
|
Amended
and Restated Bylaws of Prestige Brands Holdings, Inc., as amended
(filed
as Exhibit 3.1 to Prestige Brands Holdings, Inc.’s Form 10-Q filed on
August 9, 2006).+
|
4.1
|
|
Form of
stock certificate for common stock (filed
as Exhibit 4.1 to Prestige Brands Holdings, Inc.’s Form S-1/A filed on
January 26, 2005).+
|
4.2
|
|
Indenture,
dated April 6, 2004, among Prestige Brands, Inc., each Guarantor
thereto and U.S. Bank National Association, as Trustee (filed
as Exhibit 4.1 to Prestige Brands, Inc.’s Form S-4 filed on July 6,
2004).+
|
4.3
|
Form
of 9¼% Senior Subordinated Note due 2012 (contained in Exhibit 4.2 to
this
Annual Report on Form 10-K).+
|
|
4.4
|
Supplemental
Indenture, dated as of October 6, 2004, among Vetco, Inc., Prestige
Brands, Inc. and U.S. Bank, National Association (filed as Exhibit
4.1 to
Prestige Brands Holdings, Inc.’s Form 10-Q filed on February 9,
2007).+
|
|
4.5
|
Second
Supplemental Indenture, dated as of December 19, 2006, by and among
Prestige Brands, Inc., U.S. Bank, National Association, Prestige
Brands
Holdings, Inc., Dental Concepts LLC and Prestige International
Holdings,
LLC (filed as Exhibit 4.2 to Prestige Brands Holdings, Inc.’s Form 10-Q
filed on February 9, 2007).+
|
|
10.1
|
|
Credit
Agreement, dated April 6, 2004, among Prestige Brands, Inc.,
Prestige Brands International, LLC, the Lenders thereto, the Issuers
thereto, Citicorp North America, Inc., as Administrative Agent and as
Tranche C Agent, Bank of America, N.A., as Syndication Agent, and
Merrill Lynch Capital, a division of Merrill Lynch Business Financial
Services Inc., as Documentation Agent (filed
as Exhibit 10.1 to Prestige Brands Holdings, Inc.’s Form S-1 filed on July
28, 2004).+
|
10.2
|
|
Form of
Amendment No. 1 to the Credit Agreement, dated as of April 6,
2004, among Prestige Brands, Inc., Prestige Brands International,
LLC, the Lenders thereto, the Issuers thereto, Citicorp North
America, Inc., as administrative agent, Bank of America, N.A., as
syndication agent, and Merrill Lynch Capital, a division of Merrill
Lynch
Business Financial Services, Inc., as documentation agent
(filed
as Exhibit 10.1.1 to Prestige Brands Holdings, Inc.’s Form S-1/A filed on
February 8, 2005).+
|
10.3
|
|
Pledge
and Security Agreement, dated April 6, 2004, by Prestige
Brands, Inc. and each of the Grantors party thereto, in favor of
Citicorp North America, Inc. as Administrative Agent and
Tranche C Agent (filed
as Exhibit 10.2 to Prestige Brands Holdings, Inc.’s Form S-1 filed on July
28, 2004).+
|
10.4
|
Joinder
Agreement, dated as of December 19, 2006, by Prestige Brands Holdings,
Inc., Prestige International Holdings, LLC and Dental Concepts
LLC in
favor of Citicorp North America, Inc., as Administrative Agent,
to the
Pledge and Security Agreement, dated as of April 6, 2004, by Prestige
Brands, Inc. and its subsidiaries and affiliates listed on the
signature
pages thereof in favor of Citicorp North America, Inc., as Administrative
Agent (filed as Exhibit 10.1 to Prestige Brands Holdings, Inc.’s Form 10-Q
filed on February 9, 2007).+
|
|
10.5
|
Guaranty,
dated as of April 6, 2004, by Prestige Brands International, LLC
and each
of the other entities listed on the signature pages thereof in
favor of
Citicorp North America, Inc., as Administrative Agent (filed as
Exhibit
10.2 to Prestige Brands Holdings, Inc.’s Form 10-Q filed on February 9,
2007).+
|
|
10.6
|
Guaranty
Supplement, dated as of December 19, 2006, by Prestige Brands Holdings,
Inc., Prestige International Holdings, LLC and Dental Concepts
LLC in
favor of Citicorp North America, Inc., as Administrative Agent,
to the
Guaranty, dated as of April 6, 2004, among Prestige Brands International,
LLC and certain subsidiaries and affiliates of Prestige Brands,
Inc.
listed on the signature pages thereof in favor of Citicorp North
America,
Inc., as Administrative Agent (filed as Exhibit 10.3 to Prestige
Brands
Holdings, Inc.’s Form 10-Q filed on February 9, 2007).+
|
|
10.7
|
Securityholders
Agreement, dated February 6, 2004, among Medtech/Denorex, LLC, GTCR
Fund VIII, L.P., GTCR Fund VIII/B, L.P., GTCR Co-Invest II,
L.P., GTCR Capital Partners, L.P., the TCW/Crescent Purchasers
and the
TCW/Crescent Lenders thereto, each Executive thereto and each of
the Other
Securityholders thereto (filed as Exhibit 10.11 to Prestige Brands
Holdings, Inc.’s Form S-1 filed on July 28, 2004).+
|
|
10.8
|
First
Amendment and Acknowledgement to Securityholders Agreement, dated
April 6, 2004, to the Securityholders Agreement, dated
February 6, 2004, among Medtech/Denorex, LLC, GTCR Fund VIII,
L.P., GTCR Fund VIII/B, L.P., GTCR Co-Invest II, L.P., GTCR
Capital Partners, L.P., the TCW/Crescent Purchasers and the TCW/Crescent
Lenders thereto, each Executive thereto and each of the Other
Securityholders thereto (filed as Exhibit 10.12 to Prestige Brands
Holdings, Inc.’s Form S-1 filed on July 28, 2004).+
|
|
10.9
|
Registration
Rights Agreement, dated February 6, 2004, among Medtech/Denorex, LLC,
GTCR Fund VIII, L.P., GTCR Fund VIII/B, L.P., GTCR
Co-Invest II, L.P., GTCR Capital Partners, L.P., the TCW/Crescent
Purchasers and the TCW/Crescent Lenders thereto, each Executive
thereto
and each of the Other Securityholders thereto (filed
as Exhibit 10.13 to Prestige Brands Holdings, Inc.’s Form S-1 filed on
July 28, 2004).+
|
|
10.10
|
First
Amendment and Acknowledgement to Registration Rights Agreement,
dated
April 6, 2004, to the Registration Rights Agreement, dated
February 6, 2004, among Medtech/Denorex, LLC, GTCR Fund VIII,
L.P., GTCR Fund VIII/B, L.P., GTCR Co-Invest II, L.P., GTCR
Capital Partners, L.P., the TCW/Crescent Purchasers and the TCW/Crescent
Lenders thereto, each Executive thereto and each of the Other
Securityholders thereto (filed
as Exhibit 10.14 to Prestige Brands Holdings, Inc.’s Form S-1 filed on
July 28, 2004).+
|
|
10.11
|
Omnibus
Consent and Amendment to Securityholders Agreement, Registration
Rights
Agreement, Senior Management Agreements and Unit Purchase Agreement,
dated
as of July 6, 2004 (filed as Exhibit 10.29.1 to Prestige Brands
Holdings, Inc.’s Form S-1/A filed on November 12,
2004).+
|
|
10.12
|
Form of
Exchange Agreement by and among Prestige Brands Holdings, Inc.,
Prestige International Holdings, LLC and the common unit holders
listed on the signature pages thereto (filed
as Exhibit 10.39 to Prestige Brands Holdings, Inc.’s Form S-1/A filed on
January 26, 2005).+
|
|
10.13
|
Employment
Agreement, dated as of January 19, 2007, by and between Prestige
Brands
Holdings, Inc. and Mark Pettie (filed as Exhibit 10.5 to Prestige
Brands
Holdings, Inc.’s Form 10-Q filed on February 9,
2007).+@
|
|
10.14
|
Senior
Management Agreement, dated as of March 21, 2006, between Prestige
Brands
Holdings, Inc., Prestige Brands, Inc. and Peter C. Mann (filed
as Exhibit
99.1 to Prestige Brands Holdings, Inc.’s Form 8-K filed on March 23,
2006).+@
|
|
10.15
|
Form of
Amended and Restated Senior Management Agreement, dated as of January
28,
2005, by and among Prestige International Holdings, LLC, Prestige
Brands Holdings, Inc., Prestige Brands, Inc., and Peter J.
Anderson (filed
as Exhibit 10.29.7 to Prestige Brands Holdings, Inc.’s Form S-1/A filed on
January 26, 2005).+@
|
10.16
|
Executive
Employment Agreement, dated as of January 17, 2006, between Prestige
Brands Holdings, Inc. and Charles N. Jolly (filed as Exhibit 10.35
to
Prestige Brands Holdings, Inc.’s Form 10-K filed on June 14,
2006).+@
|
|
10.17
|
Letter
Agreement between Prestige Brands Holdings, Inc. and James E.
Kelly*@
|
|
10.18
|
Executive
Employment Agreement, dated as of August 21, 2006, between Prestige
Brands
Holdings, Inc. and Jean A. Boyko (filed
as Exhibit 10.1 to Prestige Brands Holdings, Inc.’s Form 10-Q filed on
November 9, 2006).+@
|
|
10.19
|
Form of
Amended and Restated Senior Management Agreement, dated as of January
28,
2005, by and among Prestige International Holdings, LLC, Prestige
Brands Holdings, Inc., Prestige Brands, Inc., and Gerard F.
Butler (filed as Exhibit 10.29.8 to Prestige Brands Holdings, Inc.’s Form
S-1/A filed on January 26, 2005).+@
|
|
10.20
|
Letter
Agreement, dated December 22, 2006, among Prestige Brands Holdings,
Inc.,
Prestige Brands, Inc. and Gerard F. Butler (filed as Exhibit 10.4
to
Prestige Brands Holdings, Inc.’s Form 10-Q filed on February 9,
2007).+#
|
|
10.21
|
Form of
Amended and Restated Senior Management Agreement, dated as of January
28,
2005, by and among Prestige International Holdings, LLC, Prestige
Brands Holdings, Inc., Prestige Brands, Inc., and Michael A.
Fink (filed
as Exhibit 10.29.9 to Prestige Brands Holdings, Inc.’s Form S-1/A filed on
January 26, 2005).+@
|
|
10.22
|
Letter
Agreement, dated April 13, 2007, by and among Prestige Brands Holdings,
Inc., Prestige Brands, Inc. and Michael A. Fink.*#
|
|
10.23
|
Form of
Amended and Restated Senior Management Agreement, dated as of January
28,
2005, by and among Prestige International Holdings, LLC, Prestige
Brands
Holdings, Inc., Prestige Brands, Inc., and Charles Shrank
(filed
as Exhibit 10.29.10 to Prestige Brands Holdings, Inc.’s Form S-1/A filed
on January 26, 2005).+@
|
|
10.24
|
Form of
Amended and Restated Senior Management Agreement, dated as of January
28,
2005, by and among Prestige International Holdings, LLC, Prestige
Brands
Holdings, Inc., Prestige Brands, Inc., and Eric M. Millar
(filed
as Exhibit 10.29.11 to Prestige Brands Holdings, Inc.’s Form S-1/A filed
on January 26, 2005).+@
|
|
10.25
|
Prestige
Brands Holdings, Inc. 2005 Long-Term Equity Incentive Plan
(filed
as Exhibit 10.38 to Prestige Brands Holdings, Inc.’s Form S-1/A filed on
January 26, 2005).+#
|
|
10.26
|
Form
of Restricted Stock Grant Agreement (filed
as Exhibit 10.1 to Prestige Brands Holdings, Inc.’s Form 10-Q filed on
August 9, 2005).+#
|
|
10.27
|
Form
of Performance Share Grant Agreement (filed
as Exhibit 10.3 to Prestige Brands Holdings, Inc.’s Form 10-Q filed on
November 9, 2006).+#
|
|
10.28
|
Form
of Nonqualified Stock Option Agreement *#
|
|
10.29
|
Contract
Manufacturing Agreement, dated February 1, 2001, among The
Procter & Gamble Manufacturing Company, P&G International
Operations SA, Prestige Brands International, Inc. and Prestige
Brands International (Canada) Corp. (filed
as Exhibit 10.31 to Prestige Brands, Inc.’s Form S-4/A filed on August 4,
2004).+**
|
|
10.30
|
Patent
and Technology License Agreement, dated October 2, 2001, between The
Procter & Gamble Company and Prestige Brands
International, Inc. (filed
as Exhibit 10.29 to Prestige Brands, Inc.’s Form S-4/A filed on August 19,
2004).+**
|
|
10.31
|
Amendment
No. 4 and Restatement of Contract Manufacturing Agreement, dated
May 1, 2002, by and between The Procter & Gamble Company and
Prestige Brands International, Inc. (filed
as Exhibit 10.33 to Prestige Brands, Inc.’s Form S-4/A filed on August 4,
2004).+**
|
|
10.32
|
Manufacturing
Agreement, dated December 30, 2002, by and between Prestige Brands
International, Inc. and Abbott Laboratories (filed
as Exhibit 10.32 to Prestige Brands, Inc.’s Form S-4/A filed on August 4,
2004).+**
|
|
10.33
|
Distribution
Agreement, dated April 24, 2003, by and between Medtech
Holdings, Inc. and OraSure Technologies, Inc. (filed
as Exhibit 10.27 to Prestige Brands, Inc.’s Form S-4/A filed on August 4,
2004).+**
|
|
10.34
|
Amendment
No. 1 to Distribution Agreement, dated as of February 10, 2006,
between
OraSure Technologies, Inc., Medtech Holdings, Inc. and Medtech
Products
Inc. (filed as Exhibit 10.2 to Prestige Brands Holdings, Inc.’s Form 8-K
filed on September 29, 2006).+
|
|
10.35
|
Amendment
No. 1 dated April 30, 2003 to the Patent and Technology License
Agreement, dated October 2, 2001, between The Procter &
Gamble Company and Prestige Brands International, Inc. (filed
as Exhibit 10.30 to Prestige Brands, Inc.’s Form S-4/A filed on August 19,
2004).+
|
|
10.36
|
Storage
and Handling Agreement dated April 13, 2005 by and between
Warehousing Specialists, Inc. and Prestige Brands, Inc. (filed
as Exhibit 10.1 to Prestige Brands Holdings, Inc.’s Form 8-K filed on
April 15, 2005).+
|
|
10.37
|
Transportation
Management Agreement dated April 13, 2005 by and between Prestige
Brands, Inc. and Nationwide Logistics, Inc. (filed
as Exhibit 10.2 to Prestige Brands Holdings, Inc.’s Form 8-K filed on
April 15, 2005).+
|
|
10.38
|
Trademark
License and Option to Purchase Agreement, dated September 8, 2005,
by and
among The Procter & Gamble Company and Prestige Brands Holdings, Inc.
(filed as Exhibit 10.1 to Prestige Brands Holdings, Inc.’s Form 8-K filed
on September 12, 2005).+
|
|
10.39
|
Exclusive
Supply Agreement, dated as of September 18, 2006, among Medtech
Products
Inc., Pharmacare Limited, Prestige Brands Holdings, Inc. and Aspen
Pharmacare Holdings Limited (filed
as Exhibit 10.2 to Prestige Brands Holdings, Inc.’s Form 10-Q filed on
November 9, 2006).+
|
|
21.1
|
Subsidiaries
of the Registrant.*
|
|
23.1
|
Consent
of PricewaterhouseCoopers LLP.*
|
|
31.1
|
Certification
of Principal Executive Officer of Prestige Brands Holdings, Inc.
pursuant
to Rule 13a-14(a) of the Securities Exchange Act of 1934, as adopted
pursuant to Section 302 of the Sarbanes-Oxley Act of
2002.*
|
|
31.2
|
Certification
of Principal Financial Officer of Prestige Brands Holdings, Inc.
pursuant
to Rule 13a-14(a) of the Securities Exchange Act of 1934, as adopted
pursuant to Section 302 of the Sarbanes-Oxley Act of
2002.*
|
|
32.1
|
Certification
of Principal Executive Officer of Prestige Brands Holdings, Inc.
pursuant
to Rule 13a-14(b) of the Securities Exchange Act of 1934 and Section
1350
of Chapter 63 of Title 18 of the United States Code, as adopted
pursuant
to Section 906 of the Sarbanes-Oxley Act of 2002.*
|
|
32.2
|
Certification
of Principal Financial Officer of Prestige Brands Holdings, Inc.
pursuant
to Rule 13a-14(b) of the Securities Exchange Act of 1934 and Section
1350
of Chapter 63 of Title 18 of the United States Code, as adopted
pursuant
to Section 906 of the Sarbanes-Oxley Act of
2002.*
|
* | Filed herewith. |
**
|
Certain
confidential portions have been omitted pursuant to a confidential
treatment request separately filed with the Securities and Exchange
Commission.
|
+ | Incorporated herein by reference. |
@ | Represents a management contract. |
# | Represents a compensatory plan. |
· |
Annual
salary of $250,000 paid twice
monthly.
|
· |
Participation
in the Management Bonus Plan for the fiscal year ending March 31,
2008.
Payments will be made in May of every year for the preceding year,
which
ends on 3/31. You must be an employee at the end of the year to qualify.
Your target eligibility (which is dependant on the Company achieving
budget objectives) is 45% of annual salary. The actual bonus may
be
higher, lower or non-existent dependant on financial performance
of the
Company.
|
· |
Eligibility
for the Long Term Incentive Plan (LTIP) with an initial 2008 grant
of
$346,875.
|
· |
A
sign on/retention bonus of $75,000 payable in two equal installments
of
$37,500 on April 30th
,
2007 and $37,500 on April 30th,
2008. In order to earn this retention bonus you must be employed
in good
standing with the company through the payout
dates.
|
· |
Severance
Benefit of one year’s salary and target bonus if terminated for reasons
other than “cause”, conditioned on the execution of a severance
agreement.
|
· |
Medical
Insurance (eligible immediately)
|
· |
Dental
Insurance (eligible after 1 month)
|
· |
Employee
Life Insurance (eligible after 1 month, Company
paid)
|
· |
Long-term
Disability Insurance (eligible after 1 month, Company
paid)
|
· |
Long-term
Care Insurance (eligible after 3 months, Company
paid)
|
· |
Flexible
Spending Account (eligible after 3
months)
|
· |
401k
Plan (eligible after 6 months)
|
· |
4
weeks vacation
|
1. |
Incorporation
by Reference.
Except as modified by the terms of this Agreement, Sections 1, 2,
3, 5, 6,
7(b), 8, 9, 10, 11, and 12 (but not Section
12(g)
thereof, concerning choice of law) of the Amended and Restated Senior
Management Agreement between and among Prestige International Holdings,
LLC; Prestige Brands Holdings, Inc.; Prestige Brands, Inc.; and Michael
A.
Fink, dated February 4, 2005 (the “SMA”), as they may heretofore from time
to time have been amended by the Board of Directors of the Company
and the
Compensation Committee thereof, are reaffirmed and are incorporated
herein
by reference.
|
2. |
Work
at Home.
Effective on a date to be chosen by the Company, but in any event
prior to
June 30, 2007, you will resign as an officer of Prestige by means
of a
written instrument that is substantially similar to the model letter
of
resignation that is annexed hereto as Exhibit A. Once you accept
this
offer and execute this Agreement, the Company will thereafter set
your
resignation date (the “Resignation Date”) which will be prior to June 30,
2007. Prior to the Resignation Date your efforts will be primarily
in
|
the area of transitioning your responsibilities to your replacement. For a period of 1 year following your resignation date you will become a “Work At Home” employee with no specific daily responsibilities that would require your presence at Prestige’s offices for a period of one year. During this “Work At Home” period, you will be called upon from time to time to provide advice, information or guidance to Prestige, but only with ample advance notice and response time built in. You may be invited to come to the Prestige offices, from time to time, at the Company’s initiation. Notwithstanding the foregoing, you will be under no obligation to travel or provide services according to a predetermined schedule. All company property, including but not limited to your blackberry, your mobile phone, company files and other property will be returned to the Company prior to the “Work At Home” period. Notwithstanding the foregoing, you will have the option of purchasing your laptop at its net book value at the commencement of your “Work At Home” period. |
3. |
Salary
Continuation.
After your resignation as an officer of the Company your current
salary
and benefits, including bonus eligibility, will continue. During
the year
beginning on April 1, 2007 and continuing through the Work at Home
period,
your annual salary rate shall be $211,000 and shall be paid twice
monthly,
consistent with the Company’s normal payroll practices. During the “Work
At Home” period, your health, dental, death and disability insurance
benefits shall continue; but your 401(k), vacation and cafeteria
plans
will not continue. Your salary shall be paid notwithstanding any
consulting or other non-company employment you may choose to undertake,
so
long as you are not in breach of the terms set forth in this offer.
Notwithstanding the foregoing, to the extent that the salary payments
required by this Section
3
may be deemed part of a nonqualified deferred compensation plan described
in Section 409A of the Internal Revenue Code (the “Code”), see
26
U.S.C. § 409A (2006), those payments may be deferred as may be required to
avoid adverse tax consequences to the Employee; if any such deferral
is
made, however, the payment of all accrued unpaid salary shall be
made in
one lump sum not more than two weeks after the earliest date permitted
for
that purpose by Section 409A(a)(2)(B)(i) of the Code; and all further
payments shall be made bi-weekly, consistent with the Company’s normal
payroll practices.
|
4. |
Continued
Vesting of Carried Shares.
For the balance of the fiscal year ending March 31, 2007, during
the
fiscal year beginning April 1, 2007 and during the “Work At Home” period,
the Carried Shares (as defined in the SMA) held by you will continue
to
vest pursuant to the time schedule set forth in Section 2 of the
SMA.
Provided that you are not in breach of this Agreement on the last
day of
the “Work At Home” period, any remaining Unvested Carried Shares shall be
repurchased by the Company on the last day of said period pursuant
to
Section 3 of the SMA. Your sale of any
|
Vested Carried or Co-invest shares will continue to be subject to the terms and conditions set forth in Sections 5 and 6 of the SMA. |
5. |
Bonus
Eligibility.
During the fiscal year ending on March 31, 2007, you will be eligible
for
an annual bonus, as determined by the Compensation Committee and
the Board
of Directors and also subject to the performance of the Company against
the established bonus objectives. You will not
be
eligible to receive a bonus for the fiscal year beginning on April
1,
2007. Notwithstanding the foregoing, on or about May 1, 2008, you
will
receive a payment equivalent to the greater of (i) the bonus paid
to you
for the fiscal year ending on March 31, 2007 (if any), or (ii) a
target
bonus of 45% of your entire day-to-day salary set forth in Section
3
of
this Agreement.
|
6. |
Vacation.
Any accrued but unused vacation time for calendar years 2006 and
2007 will
be paid to you, subject to applicable withholdings, promptly after
beginning your “Work At Home” period. You will not accrue vacation during
your “Work At Home” period.
|
7. |
Accelerated
Vesting.
Effective immediately and throughout the term of this Agreement,
if there
should be a Sale of the Company (defined at Section 10 of the SMA)
or if
you should you die or become disabled, all of your Carried Shares
shall
become fully vested immediately upon the closing of the Sale of the
Company or upon your death or the commencement of your
disability.
|
8. |
Non-Disparagement.
Effective immediately, and throughout the term of this Agreement,
you
agree not to disparage, criticize, defame, or make critical comment
regarding Prestige or any of the directors, officers, or employees
of
Prestige in any writing, statement, or other written or oral
communication. During the same period of time, the Company and its
directors, officers and employees agree not to disparage, criticize,
defame or make critical comment regarding you in any writing, statement,
or other written or oral communication.
|
9. |
Confidentiality.
You agree to maintain confidentiality of all non-public, trade secret
or
commercially sensitive information that has been revealed to you
during
the course of your employment, whether such information was first
obtained
during your “Work At Home” period or at any time prior thereto. You agree
that you will not disclose to any third parties, directly or indirectly
(except to the extent required by law, or if requested by the Company),
any such confidential or proprietary information (a) which has not
been
disclosed publicly by the Company, (b) which is otherwise not a matter
of
public knowledge or your personal knowledge from sources unrelated
to the
Company, or (c) which is a matter of public knowledge but you know
that
such information became a matter of public
|
knowledge through an unauthorized disclosure. You further agree to treat this Agreement as confidential and will disclose its terms to no one other than your family members and your personal legal and financial advisors, with the understanding that such disclosures will be treated as confidential. Notwithstanding the foregoing, you will be permitted to disclose that this Agreement imposes upon you the duties set forth in Sections 8, 9 and 14 hereof. |
10. |
Agreed
Communication.
You and Prestige mutually agree and consent to the text of the
communication attached hereto as Exhibit A, which may not and shall
not be
used for any purposes prior to the date upon which Employee resigns
as an
officer of the Company.
|
11. |
Termination
of Employment.
One year from your Resignation Date, your employment with Prestige
shall
cease altogether. As of that date, you will be afforded all customary
and
usual termination benefits, including but not limited to the option
to
purchase COBRA health insurance. In the event that any compensation
to be
paid to Employee pursuant to the terms of Section
3
above is deemed to be a part of a nonqualified deferred compensation
plan
under Section 409A of the Code, and if such treatment for tax purposes
causes Employee to become ineligible for COBRA benefits for anything
less
than the full term of such benefits to which he would otherwise be
entitled, then the Company shall continue to provide full health
benefits
to Employee, at the Company’s sole expense, for eighteen
months.
|
12. |
Release
of Claims.
As
a condition precedent to this Agreement, you agree to execute a release
in
the form of Exhibit C hereto. You further acknowledge by your initials
appearing at the end of this Section
12
that Prestige has encouraged you to obtain counsel and to review
this
Agreement prior to execution. MF
|
13. |
Restriction
on Sale of Restricted Stock.
You acknowledge that you have been advised of the possibility that
the
Company will participate in a registered offering of the Company’s common
stock (the “Offering”). In the event that such a registered offering is
consummated, and as a condition of this Agreement, you agree that
you will
limit your participation in said offering to not more than the lesser
of
(a) the sum of the number of Vested Shares and Co-Invest Common Shares
that you own on the date that such offering is consummated, or (b)
twenty-five percent (25%) of the total number of Common Shares that
you
own on the date that such offering in consummated. Notwithstanding
anything to the contrary herein or in the SMA, including Section
5(b)
thereof, you will retain the right to Transfer, at any future date,
the
difference between the number of shares (i) that, but for the limitations
set forth in the immediately preceding sentence, you would otherwise
be
entitled to sell
|
and (ii) the amount that you actually do sell, provided that you may Transfer up to that entire difference in a single transaction or a series of transactions, occurring either on a single date or on several dates, at your sole election. Otherwise, the sale restrictions imposed by the SMA will remain in full force and effect. You also agree to cooperate in this or other similar Company activities, as requested, to the extent that it is reasonably possible to do so. |
14. |
Non-Compete.
So
long as the Company is not in breach of its obligations under this
Agreement and the release that is annexed hereto as Exhibit C, during
the
two-year period beginning on your Resignation Date, you agree not
to
compete with the Company in the areas of: (a) OTC cryogenic wart
treatment
products, (b) Devices for treatment or management of bruxism, (c)
Liquid
OTC sore throat treatment products and lozenges, (d) Inter-proximal
devices, (e) Copper scrubbers, (f) powdered cleansers and (g) pediatric
OTC medicinal products, except with the express written consent of
the
Company (which consent shall not be unreasonably withheld).
|
15. |
Lawful
Process.
Nothing set forth herein shall preclude you from responding to any
subpoena or other lawful process or order, nor shall anything herein
preclude you from discussing the terms of this Agreement or the release
that is annexed hereto as Exhibit C with your spouse, your attorney,
your
tax advisor, or your accountant. You may also disclose the terms
of this
Agreement as necessary to enforce your rights under this
Agreement.
|
16. |
Death.
In
the event of your death or disability, all amounts payable to you
hereunder shall be paid to your estate or, if you are still living,
to
you, as though you had fully performed all of your obligations hereunder
through July 1, 2008.
|
17. |
Indemnity.
The Company agrees to indemnify, defend and hold you harmless against
any
judgments, expenses, costs, attorneys’ fees, fines, or other amounts that
you may incur for liabilities that arise out of any proceedings,
class
action suits, lawsuits, mediations, arbitrations, depositions, or
litigation of any kind or nature whatsoever, now pending or that
may later
be brought or threatened against you by reason of the fact that you
were
an employee of the Company, in accordance with the Company’s
indemnification provisions existing on the date of execution of this
Agreement. These rights are in addition to any other rights that
you may
have under the Company’s bylaws, the laws of the State of New York, the
Delaware General Corporation Law, and any other applicable laws or
regulations.
|
18. |
No
Future Long Term Incentive Awards.
In consideration of the benefits conferred herein, you acknowledge
that
you will receive no additional Long Term Incentive Awards, either
in
calendar year 2007 or 2008, or at any time subsequent
thereto.
|
19. |
Attorney’s
Fees.
The Company will reimburse any reasonable attorney’s fees incurred by you
in connection with the review and negotiation of this document in
an
amount not to exceed $2,500.
|
20. |
Amendment
and Waiver. Nothing in this Agreement abrogates or otherwise amends
Section
12(k)
of
the SMA.
|
Date
Exercisable
|
Number
of Shares
|
Name
|
Jurisdiction
of Incorporation/Organization
|
|
Bonita
Bay Holdings, Inc.
|
Virginia
|
|
Dental
Concepts LLC
|
Delaware
|
|
Medtech
Holdings, Inc.
|
Delaware
|
|
Medtech
Products Inc.
|
Delaware
|
|
Pecos
Pharmaceutical, Inc.
|
California
|
|
Prestige
Acquisition Holdings, LLC
|
Delaware
|
|
Prestige
Brands Financial Corporation
|
Delaware
|
|
Prestige
Brands Holdings, Inc.
|
Virginia
|
|
Prestige
Brands, Inc.
|
Delaware
|
|
Prestige
Brands International, Inc.
|
Virginia
|
|
Prestige
Brands International, LLC
|
Delaware
|
|
Prestige
Brands (UK) Limited
|
England
and Wales
|
|
Prestige
Household Brands, Inc.
|
Delaware
|
|
Prestige
Household Holdings, Inc.
|
Delaware
|
|
Prestige
International Holdings, LLC
|
Delaware
|
|
Prestige
Personal Care Holdings, Inc.
|
Delaware
|
|
Prestige
Personal Care, Inc.
|
Delaware
|
|
Prestige
Products Holdings, Inc.
|
Delaware
|
|
The
Comet Products Corporation
|
Delaware
|
|
The
Cutex Company
|
Delaware
|
|
The
Denorex Company
|
Delaware
|
|
The
Spic and Span Company
|
Delaware
|
|
Vetco,
Inc.
|
New
York
|
|
Wartner
USA B.V.
|
Netherlands
|
1.
|
I
have reviewed this Annual Report on Form 10-K of Prestige Brands
Holdings,
Inc.;
|
2.
|
Based
on my knowledge, this report does not contain any untrue statement
of a
material fact or omit to state a material fact necessary to make
the
statements made, in light of the circumstances under which such statements
were made, not misleading with respect to the period covered by this
report;
|
3.
|
Based
on my knowledge, the financial statements, and other financial information
included in this report, fairly present in all material respects
the
financial condition, results of operations and cash flows of the
registrant as of, and for, the periods presented in this
report;
|
4.
|
The
registrant’s other certifying officer(s) and I are responsible for
establishing and maintaining disclosure controls and procedures (as
defined in Exchange Act Rules 13a-15(e) and 15(d)-15(e)) and internal
control over financial reporting (as defined in Exchange Act Rules
13a-15(f) and 15(d)-15(f)) for the registrant and
have:
|
(a)
|
Designed
such disclosure controls and procedures, or caused such disclosure
controls and procedures to be designed under our supervision, to
ensure
that material information relating to the registrant, including its
consolidated subsidiaries, is made known to us by others within those
entities, particularly during the period in which this report is
being
prepared;
|
(b)
|
Designed
such internal control over financial reporting, or caused such internal
control over financial reporting to be designed under our supervision,
to
provide reasonable assurance regarding the reliability of financial
reporting and the preparation of financial statements for external
purposes in accordance with generally accepted accounting
principles;
|
(c)
|
Evaluated
the effectiveness of the registrant’s disclosure controls and procedures
and presented in this report our conclusions about the effectiveness
of
the disclosure controls and procedures, as of the end of the period
covered by this report based on such evaluation;
and
|
(d)
|
Disclosed
in this report any change in the registrant’s internal control over
financial reporting that occurred during the registrant’s most recent
fiscal quarter (the registrant’s fourth fiscal quarter in the case of an
annual report) that has materially affected, or is reasonably likely
to
materially affect, the registrant’s internal control over financial
reporting; and
|
5.
|
The
registrant’s other certifying officer(s) and I have disclosed, based on
our most recent evaluation of internal control over financial reporting,
to the registrant’s auditors and the audit committee of the registrant’s
board of directors (or persons performing the equivalent
functions):
|
(a)
|
All
significant deficiencies and material weaknesses in the design or
operation of internal control over financial reporting which are
reasonably likely to adversely affect the registrant’s ability to record,
process, summarize and report financial information;
and
|
(b)
|
Any
fraud, whether or not material, that involves management or other
employees who have a significant role in the registrant’s internal control
over financial reporting.
|
Date:
June 14, 2007
|
/s/
MARK PETTIE
|
|
Mark
Pettie
|
|
Chief
Executive
Officer
|
1.
|
I
have reviewed this Annual Report on Form 10-K of Prestige Brands
Holdings,
Inc.;
|
2.
|
Based
on my knowledge, this report does not contain any untrue statement
of a
material fact or omit to state a material fact necessary to make
the
statements made, in light of the circumstances under which such statements
were made, not misleading with respect to the period covered by this
report;
|
3.
|
Based
on my knowledge, the financial statements, and other financial information
included in this report, fairly present in all material respects
the
financial condition, results of operations and cash flows of the
registrant as of, and for, the periods presented in this
report;
|
4.
|
The
registrant’s other certifying officer(s) and I are responsible for
establishing and maintaining disclosure controls and procedures (as
defined in Exchange Act Rules 13a-15(e) and 15(d)-15(e)) and internal
control over financial reporting (as defined in Exchange Act Rules
13a-15(f) and 15(d)-15(f)) for the registrant and
have:
|
(a)
|
Designed
such disclosure controls and procedures, or caused such disclosure
controls and procedures to be designed under our supervision, to
ensure
that material information relating to the registrant, including its
consolidated subsidiaries, is made known to us by others within those
entities, particularly during the period in which this report is
being
prepared;
|
(b)
|
Designed
such internal control over financial reporting, or caused such internal
control over financial reporting to be designed under our supervision,
to
provide reasonable assurance regarding the reliability of financial
reporting and the preparation of financial statements for external
purposes in accordance with generally accepted accounting
principles;
|
(c)
|
Evaluated
the effectiveness of the registrant’s disclosure controls and procedures
and presented in this report our conclusions about the effectiveness
of
the disclosure controls and procedures, as of the end of the period
covered by this report based on such evaluation;
and
|
(d)
|
Disclosed
in this report any change in the registrant’s internal control over
financial reporting that occurred during the registrant’s most recent
fiscal quarter (the registrant’s fourth fiscal quarter in the case of an
annual report) that has materially affected, or is reasonably likely
to
materially affect, the registrant’s internal control over financial
reporting; and
|
5.
|
The
registrant’s other certifying officer(s) and I have disclosed, based on
our most recent evaluation of internal control over financial reporting,
to the registrant’s auditors and the audit committee of the registrant’s
board of directors (or persons performing the equivalent
functions):
|
(a)
|
All
significant deficiencies and material weaknesses in the design or
operation of internal control over financial reporting which are
reasonably likely to adversely affect the registrant’s ability to record,
process, summarize and report financial information;
and
|
(b)
|
Any
fraud, whether or not material, that involves management or other
employees who have a significant role in the registrant’s internal control
over financial reporting.
|
Date:
June 14, 2007
|
/s/
PETER J. ANDERSON
|
|
Peter
J. Anderson
|
|
Chief
Financial Officer
|